Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

C3_OTHER_SKIN_EXALLC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • not C3_MELANOMA_SKIN_EXALLC
514322

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 C44
  • Hospital discharge: ICD-9 173
  • Hospital discharge: ICD-8 173
  • Cause of death: ICD-10 C44
  • Cause of death: ICD-9 173
  • Cause of death: ICD-8 173
  • Cancer registry: Topography ICD-O-3 C44
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes 3

3 out of 7 registries used, show all original rules.

29170

4. Check minimum number of events

None

29170

5. Include endpoints

None

29170

6. Filter based on genotype QC (FinnGen only)

29170

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC
Control conditions
not C3_MELANOMA_SKIN

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

List of similar endpoints to Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

None

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 29170 14059 15111
Unadjusted period prevalence (%) 5.76 4.79 6.66
Median age at first event (years) 68.70 67.40 69.91

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
12015
Matched controls
100806
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
323.0
503
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
9.5
323.0
1794
1836
A04AA02
ATC
granisetron; systemic, transdermal
132.3
323.0
470
31
S77
ICPC
Malignant neoplasm of skin
138.8
323.0
431
27
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
12.6
323.0
637
444
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
323.0
355
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
23.5
323.0
498
185
L02BG04
ATC
letrozole; oral
45.9
323.0
484
92
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
323.0
5786
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
3099.1
323.0
367
*
ZXC50
NOMESCO Finland
Cryotherapy
10.7
323.0
785
653
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
12.4
323.0
790
569
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
323.0
423
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
323.0
604
*
L57.0
ICD-10 Finland
Actinic keratosis
8.5
323.0
2739
3367
PJA12
NOMESCO Finland
Sentinel node biopsy
322.1
323.0
727
20
115
Kela drug reimbursment
Breast cancer
+∞
323.0
729
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
449.2
323.0
465
9
R23.8
ICD-10 Finland
Other and unspecified skin changes
5.4
323.0
3803
7991
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
323.0
535
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
732.9
323.0
816
10
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
734.8
323.0
341
*
TQW99
NOMESCO Finland
Other minor procedure on skin
8.6
323.0
1239
1335
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
101.2
323.0
453
39
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
323.0
2190
*
ZZR00
NOMESCO Finland
Flap of skin
43.9
323.0
939
194
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1143.5
323.0
4787
58
C61
ICD-10 Finland
Malignant neoplasm of prostate
292.8
323.0
570
17
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
32.1
323.0
4278
1707
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
5.8
323.0
1383
2225
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
2315.4
323.0
545
*
S18
ICPC
Laceration/cut
2.5
323.0
6139
29565
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
407.5
323.0
378
8
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
548
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
323.0
551
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
429.0
323.0
1759
40
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
932.7
323.0
532
5
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
323.0
1062
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
220.0
323.0
430
17
SPAT1153
SPAT
Removal of sutures
2.5
323.0
4925
22256
H02AB02
ATC
dexamethasone; systemic
18.8
323.0
827
395
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
7.2
323.0
2578
3700
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
12.4
322.7
628
447
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
314.8
322
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
571.5
314.4
332
5
DHB00
NOMESCO Finland
Excision of lesion of external nose
49.3
304.7
393
69
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
205.9
281.9
311
13
WF002
NOMESCO Finland
Radical radiotherapy
45.7
279.1
365
69
WF003
NOMESCO Finland
Adjuvant radiotherapy
202.5
277.1
306
13
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
617.5
273.1
288
*
L03AA13
ATC
pegfilgrastim; parenteral
818.1
273.0
286
*
HAC20
NOMESCO Finland
Total mastectomy
120.1
267.1
307
22
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
10.4
262.8
555
465
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
21.5
262.2
412
166
L82
ICD-10 Finland
Seborrhoeic keratosis
2.5
260.9
2568
9987
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
253.9
260
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
750.7
250.5
263
*
D06BB10
ATC
imiquimod; topical
5.2
244.7
836
1426
L02BA01
ATC
tamoxifen; oral
80.1
240.8
289
31
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
194.6
225.8
250
11
116
Kela drug reimbursment
Prostate cancer
+∞
225.5
231
*
JN4BD
NOMESCO Finland
Extensive body CT
4.1
225.4
989
2175
ZXC15
NOMESCO Finland
Use of photodynamic technique
18.4
214.2
354
166
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
89.9
212.9
252
24
L01BC06
ATC
capecitabine; oral
+∞
211.8
217
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
13.7
208.6
386
243
A03FA01
ATC
metoclopramide; systemic, rectal
2.5
201.2
1805
6574
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
453.2
200.1
213
*
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
6.3
199.3
575
792
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
1661.1
195.8
203
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
191.2
196
*
C50.99
ICD-10 Finland
Breast, unspecified
567.4
189.2
200
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
422.8
186.5
199
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
795.7
178.3
187
*
A04AA55
ATC
palonosetron, combinations; systemic
1505.8
178.2
185
*
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
168.8
177.1
198
10
HA1AA
NOMESCO Finland
X-ray mammography
4.4
176.7
704
1403
L03AA02
ATC
filgrastim; parenteral
60.4
175.7
219
31
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.2
173.1
588
989
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
172.6
177
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
170.7
175
*
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
169.7
174
*
XX3DW
NOMESCO Finland
Time consuming IT work
3.6
168.8
854
2107
8091/3-C44.9
ICD-O-3
Superficial basal cell carcinoma of skin, NOS
1544.2
167.5
174
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
166.8
171
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
166.8
171
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
92.8
166.3
196
18
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
161.9
166
*
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
700.6
156.9
165
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
353.4
155.5
167
*
S82
ICPC
Naevus/mole
2.3
153.1
1676
6681
JN4AD
NOMESCO Finland
Body CT examination
4.1
152.9
648
1367
ZZA00
NOMESCO Finland
Split skin graft
5.5
151.5
486
763
S21
ICPC
Skin texture symptom/complaint
2.3
149.7
1682
6783
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
148.2
152
*
C50
ICD-10 Finland
Malignant neoplasm of breast
230.3
147.8
162
6
XQ848
NOMESCO Finland
Dermatological photography
5.4
146.9
477
760
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
228.8
146.8
161
6
A04AA01
ATC
ondansetron; systemic, rectal
4.9
145.6
522
930
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
143.3
147
*
A04AD12
ATC
aprepitant; systemic
428.9
142.6
152
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
142.4
3213
16989
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
33.5
141.8
197
50
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
5.8
141.6
434
644
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
1271.4
141.2
147
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
6.4
140.8
403
547
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.5
140.3
454
720
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
21.6
139.5
218
86
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
68.1
137.2
168
21
S29
ICPC
Skin symptom/complaint other
2.0
136.8
2131
9852
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
136.5
140
*
ZZA50
NOMESCO Finland
Full thickness skin graft
45.6
135.7
177
33
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
4.8
133.0
482
868
ZXC20
NOMESCO Finland
Use of chemical agents
7.5
130.4
331
378
ZX080
NOMESCO Finland
Image guided radiotherapy
383.0
127.1
136
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
125.7
129
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
124.7
128
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
67.1
122.4
150
19
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
12.3
120.5
233
162
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
3.6
119.3
602
1474
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
118.9
122
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
118.9
122
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
21.4
117.6
184
73
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
3.1
115.0
685
1900
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
114.0
117
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
155.0
113.9
128
7
C44.3
ICD-10 Finland
Malignant neoplasm: Skin of other and unspecified parts of face
260.3
112.1
122
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
110.1
113
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
39.0
109.5
147
32
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
4.1
109.4
467
988
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
109.1
112
*
L03AA14
ATC
lipegfilgrastim; parenteral
964.5
109.1
114
*
X76
ICPC
Malignant neoplasm breast female
328.5
108.7
117
*
Y77
ICPC
Malignant neoplasm prostate
116.7
107.8
124
9
XQ845
NOMESCO Finland
Dermatoscopy
8.4
107.0
253
258
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
199.9
106.9
118
5
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
106.2
109
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
105.2
108
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
71.8
104.7
127
15
8090/3-C44.0
ICD-O-3
Basal cell carcinoma, NOS, of skin of lip, NOS
+∞
103.3
106
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
913.2
103.2
108
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
904.7
102.3
107
*
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
191.3
102.1
113
5
ZX070
NOMESCO Finland
Intensity modified radiotherapy
122.8
101.4
116
8
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
18.7
101.0
165
75
CBB30
NOMESCO Finland
Excision of lesion of eyelid
3.7
100.1
481
1129
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
13.5
99.4
184
116
Z51.5
ICD-10 Finland
Palliative care
5.9
97.8
295
429
C44.01
ICD-10 Finland
Basocellular carcinoma of the lip skin
434.3
96.7
103
*
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
11.0
96.3
196
152
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
430.0
95.7
102
*
ZQZ00
NOMESCO Finland
Treatment of several skin areas
28.3
94.9
137
41
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
94.5
97
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
94.5
97
*
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
285.6
94.2
102
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
114.2
93.8
108
8
C44
ICD-10 Finland
Other malignant neoplasms of skin
85.4
93.5
111
11
WF004
NOMESCO Finland
Palliative radiotherapy
175.9
93.5
104
5
CBA10
NOMESCO Finland
Biopsy of eyelid
9.5
93.4
205
184
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
92.5
95
*
DAB00
NOMESCO Finland
Excision of lesion of auricle
12.4
90.0
173
119
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
19.9
89.5
143
61
D06BX02
ATC
ingenol mebutate; topical
6.2
88.6
255
349
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
2.8
88.5
634
1980
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.2
87.8
360
733
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
87.7
90
*
L02BB03
ATC
bicalutamide; oral
768.1
86.7
91
*
L02BG03
ATC
anastrozole; oral
57.0
86.3
108
16
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
759.6
85.7
90
*
ZXC96
NOMESCO Finland
Robot assisted procedure
8.4
85.4
201
204
WZC30
NOMESCO Finland
Teaching
2.0
85.2
1205
5280
S26
ICPC
Fear of cancer of skin
7.5
85.0
214
242
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
742.6
83.8
88
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
83.8
3448
20882
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
83.8
86
*
DAB10
NOMESCO Finland
Partial excision of auricle
133.8
83.7
95
6
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
82.8
85
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
114.7
82.6
95
7
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
81.8
84
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.8
81.2
580
1806
8070/3-C44.5
ICD-O-3
Squamous cell carcinoma, NOS, of skin of trunk
+∞
80.8
83
*
C44.40
ICD-10 Finland
Malignant tumor of the skin of the scalp and neck without histology
708.5
79.9
84
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
708.5
79.9
84
*
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
19.2
79.9
129
57
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
78.9
81
*
L02AE02
ATC
leuprorelin; implant, parenteral
9.6
77.9
169
149
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
674.5
76.0
80
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
76.0
78
*
B01AB05
ATC
enoxaparin; parenteral
1.5
73.9
2996
17973
128
Kela drug reimbursment
Cancers of female genital organs
331.7
73.5
79
*
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
24.7
72.3
108
37
C84.0
ICD-10 Finland
Mycosis fungoides
640.5
72.2
76
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
72.1
74
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
72.1
74
*
127
Kela drug reimbursment
Transplant complication
4.7
71.5
263
481
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
71.4
2590
15113
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
631.9
71.2
75
*
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
19.3
70.8
114
50
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
135.1
70.6
80
5
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
9.3
70.0
155
142
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
164.6
69.9
78
*
C44.59
ICD-10 Finland
Malignant tumor of the skin on the trunk other or unspecified histology
+∞
69.1
71
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
109.7
67.6
78
6
D22
ICD-10 Finland
Melanocytic naevi
2.7
67.0
493
1563
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
108.3
66.7
77
6
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
19.9
66.6
106
45
Z51.0
ICD-10 Finland
Radiotherapy session
205.3
66.4
73
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
66.2
68
*
S08
ICPC
Skin colour change
2.4
65.4
599
2145
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
581.0
65.4
69
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
47.3
65.2
84
15
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
16.9
64.2
108
54
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
63.8
1944
10825
L02BG06
ATC
exemestane; oral
564.0
63.4
67
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
564.0
63.4
67
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
564.0
63.4
67
*
TQW20
NOMESCO Finland
Tatoe
33.0
62.1
86
22
ZX120
NOMESCO Finland
Intravenous
2.1
61.3
777
3238
HAB99
NOMESCO Finland
Other partial excision of mammary gland
5.9
61.0
181
259
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
2.7
60.7
449
1428
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
60.4
62
*
J01DB01
ATC
cefalexin; oral
1.4
58.9
9070
68877
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.1
58.1
338
919
C90.0
ICD-10 Finland
Multiple myeloma
263.5
58.1
63
*
TQW40
NOMESCO Finland
Remowal of suture of skin
2.0
58.1
817
3549
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
3.6
57.9
285
683
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
57.8
4400
29587
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.0
57.8
761
3220
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
57.4
59
*
WX402
NOMESCO Finland
General anaesthesia
1.7
56.8
1448
7662
JN4CD
NOMESCO Finland
Very extensive body CT
3.8
56.7
255
566
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.2
56.5
651
2602
C44.19
ICD-10 Finland
Malignant tumor of the skin of the eyelids including corner of the eye or other unspecified histology
+∞
56.5
58
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
54.5
56
*
A79
ICPC
Malignancy NOS
40.5
54.4
72
15
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
250.2
54.3
59
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
53.6
4521
30814
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
10.7
53.5
109
86
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.7
53.2
194
353
WW500
NOMESCO Finland
Blood transfusion
3.7
53.0
252
587
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
52.6
54
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
6.8
52.4
140
174
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
241.4
52.3
57
*
B01AB10
ATC
tinzaparin; parenteral
2.3
51.9
526
1981
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
51.6
53
*
KC1GB
NOMESCO Finland
Cystography with X-ray
27.1
51.1
74
23
R4110
NOMESCO Finland
Physiotherapy
1.4
51.0
2593
16099
C82.1
ICD-10 Finland
Follicular lymphoma grade II
453.6
50.9
54
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
232.6
50.4
55
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
49.6
51
*
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
2.6
49.2
375
1214
1733A
ICD-9 Finland
Other malignant neoplasm of skin, Skin of other and unspecified parts of face[KASVOJEN IHON SYÖPÄ,CA BASOCELLULARE]
+∞
48.7
50
*
WX110
NOMESCO Finland
Local anesthesy
1.3
48.2
7185
53150
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
34.2
47.5
65
16
S79
ICPC
Neoplasm skin benign/unspecified
3.5
47.5
240
588
E0000UV
ATC
NA
1.4
47.3
3910
26406
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
+∞
46.7
48
*
Z94.0
ICD-10 Finland
Kidney transplant status
4.3
46.5
185
368
XW000
NOMESCO Finland
Bone marrow biopsy
2.7
46.2
330
1026
XKD00
NOMESCO Finland
Uroflowmetry
1.6
45.9
1220
6508
ZXA00
NOMESCO Finland
Right side
1.4
45.7
2774
17742
8070/3-C44.7
ICD-O-3
Squamous cell carcinoma, NOS, of skin of lower limb and hip
+∞
45.7
47
*
8070/3-C44.2
ICD-O-3
Squamous cell carcinoma, NOS, of external ear
+∞
45.7
47
*
ZXA05
NOMESCO Finland
Left side
1.4
45.5
2555
16112
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
44.8
46
*
8097/3-C44.3
ICD-O-3
Basal cell carcinoma, nodular of skin of other and unspecified parts of face
+∞
44.8
46
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
44.8
46
*
D23.9
ICD-10 Finland
Benign neoplasm: Skin, unspecified
3.0
44.7
275
779
N02AA05
ATC
oxycodone; systemic
1.7
44.3
984
4986
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
87.6
44.2
52
5
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.6
44.2
1359
7522
WX002
NOMESCO Finland
Sedation and analgesia
1.5
43.9
2061
12540
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
43.8
45
*
ZX112
NOMESCO Finland
Subcutaneous
5.1
43.6
146
243
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
137.5
43.5
49
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
85.9
43.3
51
5
TQW80
NOMESCO Finland
Local dermatologic skincare
2.7
43.2
323
1034
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.0
43.1
568
2400
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
15.6
43.0
74
40
8070/3-C44.6
ICD-O-3
Squamous cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
42.8
44
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
46.3
42.8
55
10
KCD02
NOMESCO Finland
Transurethral resection of bladder
9.9
42.5
90
77
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
377.3
42.2
45
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
41.8
43
*
8070/3-C44.4
ICD-O-3
Squamous cell carcinoma, NOS, of skin of scalp and neck
+∞
41.8
43
*
S15
ICPC
Foreign body in skin
1.9
41.8
672
3062
UJF32
NOMESCO Finland
Coloscopy
1.4
41.8
2592
16599
L04AD01
ATC
ciclosporin; systemic
3.0
41.3
258
738
ZZR10
NOMESCO Finland
Flap of skin and muscle
13.9
41.1
74
45
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
3.3
41.0
216
548
L04AA06
ATC
mycophenolic acid; systemic
3.1
40.9
241
663
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
40.9
42
*
N02BE01
ATC
paracetamol; systemic, rectal
1.4
40.7
9555
74531
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
35.6
40.7
55
13
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
60.2
40.6
50
7
QAE99
SPAT
NA
6.1
40.5
116
160
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
40.4
1112
5976
C44.99
ICD-10 Finland
Unspecified localization of malignant tumor in skin other or unspecified histology
360.3
40.3
43
*
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
3.5
40.1
203
499
1CD02
NOMESCO Finland
NA
+∞
39.9
41
*
9700/3-C44.9
ICD-O-3
Mycosis fungoides of skin, NOS
+∞
39.9
41
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
39.9
41
*
WXQ41
NOMESCO Finland
Photodynamic therapy of head and neck
52.6
39.8
50
8
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
8.1
39.7
94
98
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
79.2
39.6
47
5
ZZS00
NOMESCO Finland
Rotation flap
37.2
39.6
53
12
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
351.9
39.3
42
*
J01MA02
ATC
ciprofloxacin; systemic
1.3
39.0
3821
26278
L04AA01
ATC
[U] ciclosporin; systemic
3.2
38.8
219
583
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
94.7
38.7
45
*
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
3.5
38.6
193
470
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
38.0
39
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
37.1
1230
6916
L02BX02
ATC
degarelix; parenteral
+∞
37.0
38
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
37.0
38
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
37.0
973
5162
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
2.9
36.2
229
662
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
168.3
36.1
40
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
36.0
37
*
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
+∞
36.0
37
*
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
+∞
36.0
37
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
16.1
36.0
61
32
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
11.9
35.9
69
49
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
88.4
35.9
42
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
88.4
35.9
42
*
JN6AD
NOMESCO Finland
CT of torso and neck
8.2
35.5
83
85
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
6.3
35.5
99
132
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.8
35.5
659
3151
ZX095
NOMESCO Finland
Combined chemoradiotherapy
317.9
35.4
38
*
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
3.3
35.3
192
500
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.7
35.1
739
3678
R50.9
ICD-10 Finland
Fever, unspecified
1.6
35.1
1030
5619
C44.70
ICD-10 Finland
Malignant tumor of the skin of the lower extremity including the hip without histology
+∞
35.0
36
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
35.0
36
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
35.0
36
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
6.8
34.6
92
115
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
21.9
34.1
52
20
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
+∞
34.1
35
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
34.1
35
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
34.1
35
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
34.1
35
*
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
34.1
35
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
4.9
34.0
117
202
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
33.9
1205
6876
D70.82
ICD-10 Finland
Drug-induced neutropenia
6.6
33.6
91
117
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
23.4
33.4
50
18
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.6
33.3
990
5415
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
8.7
33.2
75
73
8832/3-C44.5
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin of trunk
+∞
33.1
34
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
33.1
34
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
28.3
33.1
47
14
D06BX01
ATC
metronidazole; topical
1.5
32.9
1100
6189
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
32.6
1737
10765
C44.90
ICD-10 Finland
Unspecified localization of malignant tumor of the skin without histology
292.5
32.5
35
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.9
32.4
142
311
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
32.1
33
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
32.1
33
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
32.1
33
*
QAE20
NOMESCO Finland
Excision and repair of scar or web of skin of head or neck
8.2
31.7
74
76
XX1XN
NOMESCO Finland
Other isotope examination
284.0
31.6
34
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
284.0
31.6
34
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
284.0
31.6
34
*
C44.20
ICD-10 Finland
Malignant tumor of the skin of the outer ear and of the outer ear canal without histology
147.2
31.3
35
*
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
+∞
31.1
32
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
31.1
32
*
C44.00
ICD-10 Finland
Malignant tumor of the lip skin without histology
+∞
31.1
32
*
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
6.7
31.1
83
105
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
38.3
30.9
41
9
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
275.5
30.6
33
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.9
30.5
469
2101
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
143.0
30.4
34
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.3
30.2
3281
22696
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
+∞
30.2
31
*
L01CA04
ATC
vinorelbine; systemic
+∞
30.2
31
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
30.2
31
*
TQW40
SPAT
NA
2.1
29.9
355
1436
L91.0
ICD-10 Finland
Hypertrophic scar
3.8
29.7
133
298
XX1AD
NOMESCO Finland
Other CT-examination
31.4
29.6
41
11
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
3.7
29.6
134
303
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
5.4
29.5
93
146
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
29.3
1777
11245
WW300
NOMESCO Finland
Transfer of autologic stem cells
95.3
29.3
34
*
M05BX04
ATC
denosumab; parenteral
2.1
29.3
364
1500
J05AB11
ATC
valaciclovir; oral
1.5
29.2
1212
7143
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
29.2
30
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
29.2
30
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
29.2
30
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
6.0
29.1
84
118
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
24.1
29.1
43
15
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
50.5
28.6
36
6
HAE99
NOMESCO Finland
Other reconstruction of breast
13.9
28.5
51
31
B07.9
ICD-10 Finland
Verruca simplex
2.1
28.4
321
1272
153
Kela drug reimbursment
Lenalidomid
92.5
28.4
33
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
28.2
29
*
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
+∞
28.2
29
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
28.2
29
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
24.6
27.9
41
14
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
2.2
27.9
305
1190
SPAT1325
SPAT
Vaccination
1.3
27.8
3298
23019
UKC02
NOMESCO Finland
Cystoscopy
1.4
27.8
1250
7483
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
49.1
27.7
35
6
S04
ICPC
Lump/swelling localized
1.6
27.7
860
4750
R23
ICD-10 Finland
Other skin changes
3.5
27.6
134
321
D04.9
ICD-10 Finland
Carcinoma in situ: Skin, unspecified
11.7
27.6
53
38
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.4
27.6
253
908
TKE00
NOMESCO Finland
Needle biopsy of prostate
2.9
27.4
178
525
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
27.2
28
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
27.2
28
*
D23
ICD-10 Finland
Other benign neoplasms of skin
2.7
27.1
196
618
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
5.4
27.0
84
130
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.2
26.9
5316
39374
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
245.2
26.8
29
*
J01MA12
ATC
levofloxacin; systemic
1.4
26.6
1572
9891
L04AX04
ATC
lenalidomide; oral
126.1
26.6
30
*
SPAT1211
SPAT
Application of soft bandage
1.6
26.6
825
4552
N63
ICD-10 Finland
Unspecified lump in breast
1.9
26.5
430
1966
I78.1
ICD-10 Finland
Naevus, non-neoplastic
2.4
26.4
244
881
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
26.3
27
*
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
26.3
27
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
13.0
26.3
48
31
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
26.2
2212
14723
D23.2
ICD-10 Finland
Benign neoplasm: Skin of ear and external auricular canal
3.9
26.1
112
242
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
5.9
26.0
76
109
J05AB01
ATC
aciclovir; systemic
1.3
26.0
1956
12795
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.9
25.9
429
1975
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
13.2
25.8
47
30
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
11.4
25.7
50
37
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
121.9
25.6
29
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
84.1
25.6
30
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
18.2
25.5
41
19
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.8
25.5
173
527
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
25.3
26
*
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
25.3
26
*
EAA20
NOMESCO Finland
Partial excision of upper lip
+∞
25.3
26
*
L01AX03
ATC
temozolomide; systemic
+∞
25.3
26
*
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
+∞
25.3
26
*
8094/3-C44.9
ICD-O-3
Basosquamous carcinoma of skin, NOS
+∞
25.3
26
*
G04BE03
ATC
sildenafil; oral
5.0
25.3
84
141
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
63.1
24.7
30
*
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
117.7
24.7
28
*
C44.60
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including the shoulder without histology
117.7
24.7
28
*
C44.5
ICD-10 Finland
Malignant neoplasm: Skin of trunk
117.7
24.7
28
*
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
81.3
24.7
29
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
15.4
24.6
42
23
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
24.5
2444
16632
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
5.1
24.5
80
132
A02BC02
ATC
pantoprazole; systemic
1.2
24.4
6820
52175
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
6.9
24.3
63
77
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
24.3
25
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
24.3
25
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
24.3
25
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.4
24.3
221
793
A12AA04
ATC
calcium carbonate; oral
2.8
24.3
164
498
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.6
24.2
724
3959
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.5
24.2
879
5029
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
24.1
2441
16638
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
61.0
23.8
29
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
6.6
23.7
63
80
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
33.6
23.6
32
8
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
19.4
23.6
37
16
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
1.9
23.5
339
1487
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
23.3
24
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
23.3
24
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
23.3
24
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.6
23.2
569
2954
7151
FHL
Kidney transplantation
16.8
23.1
38
19
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
29.9
23.0
32
9
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
210.3
23.0
25
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
109.3
22.8
26
*
PJW99
NOMESCO Finland
Other operation on lymphatic system
109.3
22.8
26
*
SPAT1324
SPAT
Screening procedure
0.7
22.8
837
9756
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
3.2
22.8
123
322
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
22.6
2003
13390
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
22.6
729
4061
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
22.4
23
*
C44.1
ICD-10 Finland
Malignant neoplasm: Skin of eyelid, including canthus
+∞
22.4
23
*
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
40.6
22.3
29
6
F16
ICPC
Eyelid symptom/complaint
1.7
22.1
450
2217
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
1.7
22.1
437
2132
C44.12
ICD-10 Finland
Spinocellular carcinoma of the skin of the eyelids including the corner of the eye
201.7
22.0
24
*
L04AX01
ATC
azathioprine; systemic
1.8
21.9
416
2004
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.3
21.9
2303
15749
QAE30
NOMESCO Finland
Excision and repair of surgical scar in head or neck
13.7
21.9
39
24
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
105.1
21.9
25
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.6
21.8
168
553
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.7
21.5
148
455
ZZF00
NOMESCO Finland
Graft of adipose tissue
6.2
21.5
60
82
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
21.4
22
*
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
+∞
21.4
22
*
C44.69
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including shoulder other or unspecified histology
+∞
21.4
22
*
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
+∞
21.4
22
*
20199
ICD-8 Finland
Hodgkin's disease
+∞
21.4
22
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
21.4
22
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
21.4
22
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.5
21.4
178
611
EAA10
NOMESCO Finland
Excision of lesion of lip
3.0
21.3
129
366
QAE15
NOMESCO Finland
Excision of other superficial lesion of skin from head and neck
10.3
21.3
43
35
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.3
21.2
200
732
D23.4
ICD-10 Finland
Benign neoplasm: Skin of scalp and neck
3.3
21.2
111
285
WW409
NOMESCO Finland
Other aferesis
54.6
21.0
26
*
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
193.2
21.0
23
*
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.8
21.0
391
1873
WF090
NOMESCO Finland
Profylactic radiotherapy
70.1
20.9
25
*
B03XA02
ATC
darbepoetin alfa; parenteral
2.7
20.9
144
443
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.2
20.9
229
899
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.8
20.9
392
1882
Z42.0
ICD-10 Finland
Follow-up care involving plastic surgery of head and neck
10.4
20.8
42
34
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
25.2
20.7
30
10
QAA99
NOMESCO Finland
Other local destruction of skin of head or neck
7.5
20.6
50
56
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
20.4
21
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
20.4
21
*
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
+∞
20.4
21
*
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
20.4
21
*
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
20.4
21
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
20.4
21
*
HAC25
NOMESCO Finland
Radical mastectomy
+∞
20.4
21
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
43.7
20.3
26
5
C44.79
ICD-10 Finland
Malignant tumor of the skin of the lower extremity including hip or other unspecified histology
184.8
20.1
22
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.5
19.9
666
3739
A11CC03
ATC
alfacalcidol; systemic
2.2
19.9
199
749
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
2.8
19.8
134
410
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
9.3
19.7
42
38
PJA10
NOMESCO Finland
Exploration of lymph nodes
4.6
19.6
70
128
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
12.6
19.6
36
24
TK800
NOMESCO Finland
Hemodialysis
2.2
19.5
201
767
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
19.5
20
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
19.5
20
*
C21.1
ICD-10 Finland
Malignant neoplasm: Anal canal
+∞
19.5
20
*
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
+∞
19.5
20
*
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
+∞
19.5
20
*
C44.49
ICD-10 Finland
Malignant tumor of the skin of the scalp and of the neck other or unspecified histology
+∞
19.5
20
*
8070/3-C00.1
ICD-O-3
Squamous cell carcinoma, NOS, of external lower lip
+∞
19.5
20
*
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
+∞
19.5
20
*
L02BB04
ATC
enzalutamide; oral
+∞
19.5
20
*
C21.0
ICD-10 Finland
Malignant neoplasm: Anus, unspecified
+∞
19.5
20
*
C44.29
ICD-10 Finland
Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology
+∞
19.5
20
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
3.3
19.4
102
263
JG1CG
NOMESCO Finland
Extensive MRI of rectum
12.1
19.3
36
25
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
3.1
19.2
109
296
XJH00
NOMESCO Finland
Transanal ultrasonography
1.8
19.2
363
1750
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
176.4
19.1
21
*
137
Kela drug reimbursment
Uraemia requiring dialysis
3.2
19.1
102
266
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.2
19.1
192
726
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
2.0
18.9
259
1117
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.5
18.9
712
4103
JAL30
NOMESCO Finland
Omentectomy
5.2
18.7
60
98
JFF23
NOMESCO Finland
Transversostomy
5.5
18.7
57
88
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.5
18.6
152
519
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.0
18.5
109
305
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.2
18.5
195
753
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
3.2
18.5
102
273
8140/3-C18.4
ICD-O-3
Adenocarcinoma, NOS, of transverse colon
+∞
18.5
19
*
390
Kela drug reimbursment
Ibrutinib
+∞
18.5
19
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
18.5
19
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
18.5
19
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
18.5
19
*
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
4.6
18.4
65
118
QAE00
NOMESCO Finland
Excision of loose skin or fold of skin from head and neck
5.9
18.4
53
76
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
2.8
18.3
120
359
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
3.2
18.3
97
252
EAA30
NOMESCO Finland
Partial excision of lower lip
48.3
18.3
23
*
J01EA01
ATC
trimethoprim; systemic
1.3
18.3
2201
15260
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
11.9
18.1
34
24
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
33.6
17.9
24
6
KAD00
NOMESCO Finland
Partial nephrectomy
9.7
17.8
37
32
Z02.4
ICD-10 Finland
Examination for driving licence
1.3
17.7
2187
15202
D75
ICPC
Malignant neoplasm colon/rectum
20.6
17.7
27
11
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
2.7
17.6
121
374
8094/3-C44.3
ICD-O-3
Basosquamous carcinoma of skin of other and unspecified parts of face
+∞
17.5
18
*
1XC07
NOMESCO Finland
NA
+∞
17.5
18
*
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
+∞
17.5
18
*
WW402
NOMESCO Finland
Leucoferesis
+∞
17.5
18
*
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
+∞
17.5
18
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
17.5
18
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
17.5
18
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
17.5
18
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
17.5
18
*
1512
Kela drug reimbursment
Ibrutinib
+∞
17.5
18
*
L01CB01
ATC
etoposide; systemic
+∞
17.5
18
*
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
8.4
17.4
39
39
329
Kela drug reimbursment
Lenalidomide
58.9
17.3
21
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
159.6
17.2
19
*
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
159.6
17.2
19
*
TDA10
NOMESCO Finland
Needle biopsy of auricle or external auditory canal
9.5
17.1
36
32
B03XA01
ATC
erythropoietin; parenteral
3.7
16.8
76
175
M05BA04
ATC
alendronic acid; oral
1.4
16.6
713
4217
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
16.6
1469
9784
N02AX02
ATC
tramadol; systemic, rectal
1.2
16.6
4148
30945
8522/3-C50.9
ICD-O-3
Infiltrating duct and lobular carcinoma of breast, NOS
+∞
16.5
17
*
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
+∞
16.5
17
*
1AA09
NOMESCO Finland
NA
+∞
16.5
17
*
1501
Kela drug reimbursment
Palbociclib
+∞
16.5
17
*
C00.1
ICD-10 Finland
Malignant neoplasm: External lower lip
+∞
16.5
17
*
C44.4
ICD-10 Finland
Malignant neoplasm: Skin of scalp and neck
+∞
16.5
17
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
16.5
17
*
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
+∞
16.5
17
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
16.5
17
*
C50.52
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor
+∞
16.5
17
*
8480/3-C50.9
ICD-O-3
Mucinous adenocarcinoma of breast, NOS
+∞
16.5
17
*
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
+∞
16.5
17
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
16.5
17
*
G04CA02
ATC
tamsulosin; oral
1.3
16.5
1571
10564
KEB00
NOMESCO Finland
Biopsy of prostate
4.8
16.5
56
98
C56
ICD-10 Finland
Malignant neoplasm of ovary
44.1
16.5
21
*
-54
ICPC
Repair/fix-suture/cast/prosth device
2.0
16.3
222
956
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.2
16.3
2718
19499
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
30.8
16.1
22
6
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
8.0
16.0
37
39
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.6
16.0
378
1949
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.1
15.9
176
695
R22
ICD-10 Finland
Localized swelling, mass and lump of skin and subcutaneous tissue
2.1
15.9
190
777
R31
ICD-10 Finland
Unspecified haematuria
1.4
15.9
675
3987
Z49.1
ICD-10 Finland
Extracorporeal dialysis
2.5
15.8
128
436
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
1.9
15.8
252
1151
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
3.6
15.8
73
172
A06AD11
ATC
lactulose; oral
1.4
15.7
1002
6359
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
42.0
15.6
20
*
A07AA02
ATC
nystatin; oral
1.5
15.6
517
2898
L02AE04
ATC
triptorelin; parenteral
14.2
15.6
27
16
JG1BG
NOMESCO Finland
MRI of rectum
10.4
15.6
31
25
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
15.6
16
*
C44.82
ICD-10 Finland
Overall spinocellular carcinoma of the skin
+∞
15.6
16
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
15.6
16
*
L01BB05
ATC
fludarabine; systemic
+∞
15.6
16
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
15.6
16
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
15.6
16
*
394
Kela drug reimbursment
Palbociclib
+∞
15.6
16
*
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
+∞
15.6
16
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
15.6
16
*
8070/3-C44.0
ICD-O-3
Squamous cell carcinoma, NOS, of skin of lip, NOS
+∞
15.6
16
*
9650/3-C77.0
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck
+∞
15.6
16
*
D07AC01
ATC
betamethasone; topical
1.2
15.6
3352
24634
TQB05
NOMESCO Finland
Puncture of skin of trunk
4.9
15.6
52
90
D23.0
ICD-10 Finland
Benign neoplasm: Skin of lip
4.9
15.6
52
90
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
0.6
15.6
247
3402
N05CF01
ATC
zopiclone; oral
1.2
15.5
2968
21567
R23.4
ICD-10 Finland
Changes in skin texture
2.8
15.5
101
304
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.5
15.5
484
2675
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.2
15.4
168
660
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
3.5
15.3
73
176
K62.7
ICD-10 Finland
Radiation proctitis
142.8
15.3
17
*
3AA13
NOMESCO Finland
NA
142.8
15.3
17
*
9706
FHL
Ablation mammae, includes axillary exploration
75.6
15.3
18
*
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
75.6
15.3
18
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
75.6
15.3
18
*
S52
ICPC
Skin, Exc/remov/biopsy/destruc/debrid/caut
6.6
15.3
40
51
GD1AD
NOMESCO Finland
Thorax CT examination
1.7
15.3
306
1505
Z31.5
ICD-10 Finland
Genetic counselling
1.8
15.3
264
1238
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.7
15.2
107
337
JFB30
NOMESCO Finland
Right hemicolectomy
3.9
15.1
63
136
ZXA10
NOMESCO Finland
Bilateral
1.3
15.1
1611
10986
1XC02
NOMESCO Finland
NA
4.1
15.1
59
120
WW200
NOMESCO Finland
Immunization
1.9
15.1
210
915
Z71.8
ICD-10 Finland
Other specified counselling
1.2
15.0
1976
13808
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
8.2
15.0
34
35
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
3.0
15.0
88
248
HA1HA
NOMESCO Finland
Tomosynthesis mammography
7.1
14.9
37
44
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
2.0
14.8
189
796
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
3.1
14.8
82
222
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
3.1
14.8
84
230
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
5.7
14.7
43
64
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
14.6
15
*
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
+∞
14.6
15
*
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
+∞
14.6
15
*
1749X
ICD-9 Finland
Malignant neoplasm of female breast, Breast (female), unspecified
+∞
14.6
15
*
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
+∞
14.6
15
*
C18.29
ICD-10 Finland
Malignant tumor of the ascending colon or other unspecified histology
+∞
14.6
15
*
8461/3-C57.0
ICD-O-3
High grade serous carcinoma of fallopian tube
+∞
14.6
15
*
L02BA03
ATC
fulvestrant; parenteral
+∞
14.6
15
*
C50.32
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor
+∞
14.6
15
*
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
+∞
14.6
15
*
9700/3-C44.5
ICD-O-3
Mycosis fungoides of skin of trunk
+∞
14.6
15
*
A54
ICPC
General and Unspecified, Repair/fix-suture/cast/prosth device
2.3
14.5
139
516
ZX108
NOMESCO Finland
Inhalation
3.6
14.5
67
158
D01AE16
ATC
amorolfine; topical
1.3
14.4
1133
7415
H26.4
ICD-10 Finland
After-cataract
1.4
14.4
656
3923
G04BE01
ATC
alprostadil; parenteral, urethral
3.1
14.4
80
217
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
1.9
14.4
200
868
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.1
14.4
168
683
189
Kela drug reimbursment
Imatinib
134.4
14.4
16
*
C18.31
ICD-10 Finland
Malignant tumor of flexura hepatica invasive carcinoma
134.4
14.4
16
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
134.4
14.4
16
*
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
134.4
14.4
16
*
A06AH03
ATC
naloxegol; oral
4.9
14.3
47
80
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
10.7
14.3
28
22
KE1BG
NOMESCO Finland
MRI of prostate
5.7
14.2
41
60
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
5.2
14.1
44
71
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
16.1
14.0
23
12
KDE20
NOMESCO Finland
Removal of foreign body from urethra
5.3
14.0
43
68
R4190
NOMESCO Finland
Nutritional therapy
2.0
13.9
186
798
-59
ICPC
Other therap proced/minor surg NEC
1.8
13.8
231
1073
N18.0
ICD-10 Finland
End-stage renal disease
2.5
13.7
107
357
WXQ99
NOMESCO Finland
Other light therapy
13.4
13.6
24
15
C03CA01
ATC
furosemide; systemic
1.2
13.6
2097
14886
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
13.6
14
*
C07.70
ICD-10 Finland
Malignant tumor of the superficial part of the parotid gland
+∞
13.6
14
*
17331
ICD-8 Finland
Other malignant neoplasm of skin, Other and unspecified part of face
+∞
13.6
14
*
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
+∞
13.6
14
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
13.6
14
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
13.6
14
*
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
+∞
13.6
14
*
192
Kela drug reimbursment
Fulvestrant
+∞
13.6
14
*
197
Kela drug reimbursment
Sunitinib
+∞
13.6
14
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
13.6
14
*
L01XE27
ATC
[U] ibrutinib; oral
+∞
13.6
14
*
C50.93
ICD-10 Finland
Malignant tumor in other specified localization in mammary gland other or unspecified histology
+∞
13.6
14
*
JCC12
NOMESCO Finland
Thoracoscopic or laparoscopic partial oesophagectomy
+∞
13.6
14
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
125.9
13.4
15
*
TJF80
NOMESCO Finland
Ostomy education
4.5
13.4
48
90
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
1.7
13.4
277
1376
J01MA14
ATC
moxifloxacin; systemic
1.4
13.3
712
4388
9734
FHL
Excision and local plastic or associated free skin grafting
3.3
13.3
66
166
QBE99
SPAT
NA
3.3
13.3
66
166
ZZS10
NOMESCO Finland
Transposition flap
30.2
13.2
18
5
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
13.2
4863
37237
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
4.0
13.1
53
112
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
8.4
13.1
29
29
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.4
13.0
591
3538
L01BB01
ATC
NA
5.6
13.0
38
57
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
22.8
13.0
19
7
D07AB02
ATC
hydrocortisone butyrate; topical
1.2
12.9
2583
18799
G03CA04
ATC
estriol; systemic, vaginal
1.4
12.9
557
3305
L57.9
ICD-10 Finland
Skin changes due to chronic exposure to nonionizing radiation, unspecified
6.9
12.8
32
39
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.4
12.7
647
3952
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
4.6
12.7
44
80
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
5.8
12.7
36
52
S19
ICPC
Skin injury other
1.6
12.7
297
1528
75310
ICD-8 Finland
Congenital anomalies of urinary system, Ren polycysticus bilateralis
25.2
12.7
18
6
L01XE01
ATC
[U] imatinib; oral
+∞
12.6
13
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
+∞
12.6
13
*
C49.19
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor
+∞
12.6
13
*
QA6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in cheeks or nose
+∞
12.6
13
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
12.6
13
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
12.6
13
*
C18.61
ICD-10 Finland
Malignant tumor of the colon descending invasive carcinoma
+∞
12.6
13
*
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
+∞
12.6
13
*
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
+∞
12.6
13
*
19399
ICD-8 Finland
Malignant neoplasm of thyroid gland
+∞
12.6
13
*
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
12.6
13
*
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
12.6
13
*
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
+∞
12.6
13
*
8071/3-C44.9
ICD-O-3
Squamous cell carcinoma, keratinizing, NOS, of skin, NOS
+∞
12.6
13
*
L01EL01
ATC
ibrutinib; oral
+∞
12.6
13
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
12.6
13
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
12.6
13
*
C54.1
ICD-10 Finland
Malignant neoplasm: Endometrium
+∞
12.6
13
*
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
4.0
12.6
51
108
C44.9
ICD-10 Finland
Malignant neoplasm: Malignant neoplasm of skin, unspecified
63.0
12.5
15
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
12.1
12.5
23
16
L72.1
ICD-10 Finland
Trichilemmal cyst
1.4
12.5
529
3121
QAB05
NOMESCO Finland
Revision of wound of skin of head or neck
5.7
12.5
36
53
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
19.9
12.5
19
8
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
117.5
12.5
14
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
117.5
12.5
14
*
L57.8
ICD-10 Finland
Other skin changes due to chronic exposure to nonionizing radiation
4.9
12.4
41
71
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
3.3
12.4
62
157
ZX050
NOMESCO Finland
Stereotactic radiotherapy
7.6
12.4
29
32
WF099
NOMESCO Finland
Other radiotherapy
6.6
12.4
32
41
D04.0
ICD-10 Finland
Carcinoma in situ: Skin of lip
28.6
12.3
17
5
D23.6
ICD-10 Finland
Benign neoplasm: Skin of upper limb, including shoulder
3.0
12.3
72
204
X21
ICPC
Breast sympt/compl female other
2.2
12.3
122
464
JN3AD
NOMESCO Finland
Abdominal CT examination
1.4
12.3
541
3219
J02AC01
ATC
fluconazole; systemic
1.2
12.3
3831
28914
L57
ICD-10 Finland
Skin changes due to chronic exposure to nonionizing radiation
4.8
12.3
41
72
D07AB08
ATC
desonide; topical
1.3
12.3
835
5353
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
6.0
12.2
34
48
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.2
12.2
1680
11779
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
4.7
12.1
41
73
SPAT1312
SPAT
General health counselling
1.2
12.1
2929
21658
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
33.6
12.1
16
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
33.6
12.1
16
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.2
12.1
3078
22853
Z93.3
ICD-10 Finland
Colostomy status
4.8
12.0
40
70
A12BA01
ATC
potassium chloride; oral
1.6
12.0
308
1624
D48
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other and unspecified sites
6.0
12.0
33
46
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
6.0
12.0
33
46
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
2.7
12.0
83
261
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
2.6
12.0
86
275
A44
ICPC
General and Unspecified, Preventive immunization/medic
1.4
11.9
595
3626
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.5
11.9
93
313
QAA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of head or neck
3.8
11.9
50
110
H02AB04
ATC
methylprednisolone; systemic
1.2
11.9
1365
9373
205
Kela drug reimbursment
Chronic hypertension
1.2
11.9
2611
19140
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.4
11.9
568
3435
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
11.9
4114
31283
X77
ICPC
Malignant neopl genital female other
42.0
11.8
15
*
Z08
ICD-10 Finland
Follow-up examination after treatment for malignant neoplasms
42.0
11.8
15
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
4.9
11.7
38
65
B05DA
ATC
Isotonic solutions
2.8
11.7
73
216
8090/3-C44.8
ICD-O-3
Basal cell carcinoma, NOS, of overlapping lesion of skin
+∞
11.7
12
*
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
11.7
12
*
C46.0
ICD-10 Finland
Kaposi sarcoma of skin
+∞
11.7
12
*
C54.14
ICD-10 Finland
Serous papillary carcinoma of the endometrium
+∞
11.7
12
*
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
11.7
12
*
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
+∞
11.7
12
*
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
+∞
11.7
12
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
11.7
12
*
8832/3-C44.7
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin of lower limb and hip
+∞
11.7
12
*
393
Kela drug reimbursment
Pomalidomide
+∞
11.7
12
*
8140/3-C19.9
ICD-O-3
Adenocarcinoma, NOS, of rectosigmoid junction
+∞
11.7
12
*
C54.19
ICD-10 Finland
Malignant tumor of endometrium, unspecified histology
+∞
11.7
12
*
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
+∞
11.7
12
*
1742A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-inner quadrant
+∞
11.7
12
*
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
+∞
11.7
12
*
L01EF01
ATC
palbociclib; oral
+∞
11.7
12
*
155
Kela drug reimbursment
Afatinib and gefitinib
+∞
11.7
12
*
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
+∞
11.7
12
*
C54.9
ICD-10 Finland
Malignant neoplasm: Corpus uteri, unspecified
+∞
11.7
12
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
11.7
12
*
8070/3-C02.1
ICD-O-3
Squamous cell carcinoma, NOS, of border of tongue
+∞
11.7
12
*
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
+∞
11.7
12
*
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
11.7
12
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
11.7
12
*
L02BX03
ATC
abiraterone; oral
+∞
11.7
12
*
8832/3-C44.6
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin of upper limb and shoulder
+∞
11.7
12
*
JGB36
NOMESCO Finland
Wide excision of rectum
+∞
11.7
12
*
6112
FHL
Installation of a peritoneal dialysis or lavage catheter in an operating room
16.0
11.6
19
10
RS220
NOMESCO Finland
NA
2.5
11.6
92
313
XF400
NOMESCO Finland
ECG with 12 standard connections
1.2
11.6
1327
9108
A02BC05
ATC
esomeprazole; systemic
1.2
11.6
4118
31354
E000001
ATC
NA
1.2
11.6
1702
12010
1XC03
NOMESCO Finland
NA
109.1
11.5
13
*
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
109.1
11.5
13
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
109.1
11.5
13
*
KE1DR
NOMESCO Finland
Prostate metabolic PET with CT
109.1
11.5
13
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
109.1
11.5
13
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
1.8
11.5
188
871
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
5.8
11.4
32
46
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
5.8
11.4
32
46
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.3
11.4
58
150
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
9.7
11.3
23
20
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
3.3
11.3
57
146
I10
ICD-10 Finland
Essential (primary) hypertension
1.1
11.3
6154
48251
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.3
11.3
952
6291
C08CA02
ATC
felodipine; oral
1.3
11.3
771
4947
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
16.8
11.3
18
9
D04
ICD-10 Finland
Carcinoma in situ of skin
16.8
11.3
18
9
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
5.7
11.2
32
47
S80
ICPC
Solar keratosis/sunburn
5.3
11.2
34
54
C08CA01
ATC
amlodipine; oral
1.2
11.1
3471
26148
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
4.9
11.1
36
62
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
3.9
11.0
45
97
D05.0
ICD-10 Finland
Lobular carcinoma in situ
22.4
11.0
16
6
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.4
11.0
574
3527
KE1DG
NOMESCO Finland
Very extensive MRI of prostate
3.5
10.9
50
119
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
1.9
10.9
162
726
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
4.8
10.9
36
63
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.7
10.9
328
3961
QAA10
NOMESCO Finland
Incision of skin of head or neck
5.5
10.9
32
49
TKE10
NOMESCO Finland
Puncture of prostate
17.8
10.9
17
8
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
2.6
10.8
79
256
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
3.8
10.8
46
103
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
10.8
195
934
GDC00
NOMESCO Finland
Lobectomy of lung
8.8
10.8
23
22
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.4
10.8
555
3401
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
54.5
10.7
13
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
54.5
10.7
13
*
HA6HA
NOMESCO Finland
Tomosynthesis assessment of mammary gland specimen
54.5
10.7
13
*
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
+∞
10.7
11
*
C44.7
ICD-10 Finland
Malignant neoplasm: Skin of lower limb, including hip
+∞
10.7
11
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
10.7
11
*
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
10.7
11
*
C09.0
ICD-10 Finland
Malignant neoplasm: Tonsillar fossa
+∞
10.7
11
*
C83.34
ICD-10 Finland
Anaplastic large cell lymphoma
+∞
10.7
11
*
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
+∞
10.7
11
*
C50.30
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication
+∞
10.7
11
*
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
10.7
11
*
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
+∞
10.7
11
*
LE090
NOMESCO Finland
Profylactive radiotherapy of vulva and vagina
+∞
10.7
11
*
1507
Kela drug reimbursment
Pomalidomide
+∞
10.7
11
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
10.7
11
*
3054
Kela drug reimbursment
NA
+∞
10.7
11
*
1930A
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]
+∞
10.7
11
*
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
+∞
10.7
11
*
1523
Kela drug reimbursment
NA
+∞
10.7
11
*
8317/3-C64.9
ICD-O-3
Renal cell carcinoma, chromophobe type of kidney, NOS
+∞
10.7
11
*
C50.1
ICD-10 Finland
Malignant neoplasm: Central portion of breast
+∞
10.7
11
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
10.7
11
*
C18.51
ICD-10 Finland
Malignant tumor of flexura hiealis invasive carcinoma
+∞
10.7
11
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
10.7
11
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
10.7
11
*
159
Kela drug reimbursment
Pazopanib
+∞
10.7
11
*
L04AX06
ATC
pomalidomide; oral
+∞
10.7
11
*
H81
ICPC
Excessive ear wax
1.2
10.7
1358
9432
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.4
10.7
86
297
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
9.2
10.6
22
20
CBD11
NOMESCO Finland
Opening of eylid graft or flap
100.7
10.6
12
*
S27
ICPC
Fear of skin disease other
3.1
10.6
57
154
QAE35
NOMESCO Finland
Repair of skin defect in head or neck after surgery or injury
12.3
10.5
19
13
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.4
10.5
478
2865
L71.9
ICD-10 Finland
Rosacea, unspecified
1.8
10.5
189
905
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
2.6
10.5
77
251
ZZT00
NOMESCO Finland
Local skin and subcutaneous tissue flap
19.2
10.5
16
7
R60.0
ICD-10 Finland
Localized oedema
1.3
10.5
857
5640
M04AA01
ATC
allopurinol; systemic
1.3
10.5
911
6043
A04AA03
ATC
tropisetron; systemic
15.9
10.5
17
9
UJF30
NOMESCO Finland
Ileoscopy through colon
1.3
10.4
800
5218
V03AE02
ATC
sevelamer; oral
3.1
10.4
56
151
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.2
10.4
1638
11625
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
4.0
10.4
41
86
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
2.1
10.3
117
473
KAC00
NOMESCO Finland
Nephrectomy
6.3
10.3
27
36
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
2.0
10.3
138
596
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.6
10.3
267
1418
S99
ICPC
Skin disease other
1.9
10.2
150
669
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.5
10.2
340
1913
S06
ICPC
Rash localized
1.4
10.2
447
2663
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
3.5
10.2
46
109
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
1.6
10.2
232
1191
H02.1
ICD-10 Finland
Ectropion of eyelid
3.0
10.1
59
168
58200
ICD-8 Finland
Chronic nephritis, Cum uraemia
8.4
10.1
22
22
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
1.9
10.1
145
642
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.2
10.1
1668
11898
D76
ICPC
Malignant neoplasm pancreas
36.4
10.0
13
*
2180A
ICD-9 Finland
Uterine leiomyoma, Submucous leiomyoma of uterus
1.4
10.0
595
3736
Z00.0
ICD-10 Finland
General medical examination
1.2
10.0
1577
11198
QBA10
NOMESCO Finland
Incision of skin of trunk
2.5
10.0
80
274
L73.8
ICD-10 Finland
Other specified follicular disorders
2.6
10.0
70
223
45499
ICD-8 Finland
Varicose veins of lower extremities, Other and unspecified, without ulcer
1.4
9.9
501
3060
D70.89
ICD-10 Finland
Neutropenic splenomegaly
2.7
9.9
68
215
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
10.6
9.9
19
15
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
0.5
9.8
63
1113
AA1BD
NOMESCO Finland
Extensive CT of head and brain
1.9
9.8
143
639
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.3
9.8
880
5863
JDD00
NOMESCO Finland
Total gastrectomy and Roux-en-Y oesophagojejunostomy
50.4
9.8
12
*
C44.92
ICD-10 Finland
Unspecified localization of spinocellular carcinoma of the skin
50.4
9.8
12
*
4194
NOMESCO Finland
NA
50.4
9.8
12
*
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
50.4
9.8
12
*
L04AA10
ATC
sirolimus; oral
11.6
9.8
18
13
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
1.8
9.8
177
850
CBB99
NOMESCO Finland
Other excision or destruction of lesion of eyelid
3.6
9.8
44
104
L01AA02
ATC
chlorambucil; oral
9.3
9.8
20
18
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
3.6
9.8
43
100
C18.2
ICD-10 Finland
Malignant neoplasm: Ascending colon
+∞
9.7
10
*
8097/3-C44.5
ICD-O-3
Basal cell carcinoma, nodular of skin of trunk
+∞
9.7
10
*
U75
ICPC
Malignant neoplasm of kidney
+∞
9.7
10
*
3012
Kela drug reimbursment
Cabozantinib
+∞
9.7
10
*
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
9.7
10
*
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
9.7
10
*
8070/3-C44.1
ICD-O-3
Squamous cell carcinoma, NOS, of eyelid
+∞
9.7
10
*
8520/3-C50.1
ICD-O-3
Lobular carcinoma, NOS, of central portion of breast
+∞
9.7
10
*
1502
Kela drug reimbursment
Cabozantinib
+∞
9.7
10
*
8000/3-C25.9
ICD-O-3
Neoplasm, malignant of pancreas, NOS
+∞
9.7
10
*
C50.01
ICD-10 Finland
Malignant tumor of nipple and areola, ductal tumor
+∞
9.7
10
*
4CJ01
NOMESCO Finland
NA
+∞
9.7
10
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
9.7
10
*
8010/3-C50.9
ICD-O-3
Carcinoma, NOS, of breast, NOS
+∞
9.7
10
*
8410/3-C44.1
ICD-O-3
Sebaceous carcinoma of eyelid
+∞
9.7
10
*
8092/3-C44.9
ICD-O-3
Infiltrating basal cell carcinoma, NOS, of skin, NOS
+∞
9.7
10
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
9.7
10
*
316
Kela drug reimbursment
Imatinib
+∞
9.7
10
*
C16.00
ICD-10 Finland
Cardia
+∞
9.7
10
*
CKE60
NOMESCO Finland
Brachytherapy of choroid and retina
+∞
9.7
10
*
CKE65
NOMESCO Finland
Removal of brachytherapeutic plate from eye
+∞
9.7
10
*
QCA30
NOMESCO Finland
Electrocoagulation of skin of upper limb
+∞
9.7
10
*
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
9.7
10
*
8091/3-C44.5
ICD-O-3
Superficial basal cell carcinoma of skin of trunk
+∞
9.7
10
*
8140/3-C18.3
ICD-O-3
Adenocarcinoma, NOS, of hepatic flexure of colon
+∞
9.7
10
*
8070/3-C09.9
ICD-O-3
Squamous cell carcinoma, NOS, of tonsil, NOS
+∞
9.7
10
*
C66
ICD-10 Finland
Malignant neoplasm of ureter
+∞
9.7
10
*
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
+∞
9.7
10
*
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.3
9.7
1036
7051
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.2
9.7
1694
12142
G04CB02
ATC
dutasteride; oral
1.5
9.7
360
2078
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
18.0
9.7
15
7
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
14.9
9.7
16
9
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
92.3
9.7
11
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
92.3
9.7
11
*
A98
ICPC
Health maint/preventive medicine
1.3
9.5
11240
92648
V03AE01
ATC
polystyrene sulfonate; oral
2.3
9.5
86
313
D03.5
ICD-10 Finland
Melanoma in situ of trunk
5.2
9.5
29
47
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
4.6
9.5
32
58
S59
ICPC
Skin, Other therap proced/minor surg NEC
2.1
9.5
102
406
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
3.7
9.5
40
90
ZX100
NOMESCO Finland
Oral
2.3
9.5
84
306
WW200
SPAT
NA
0.8
9.5
591
6390
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
27.3
9.4
13
*
S01GX01
ATC
cromoglicic acid; ophthalmic
1.2
9.4
1673
12005
Q82.58
ICD-10 Finland
Congenital non-neoplastic naevus
2.5
9.4
71
238
JDB10
NOMESCO Finland
Percutaneous gastrostomy
2.8
9.3
58
173
H02
ICPC
Hearing complaint
1.3
9.2
1006
6862
J01FA10
ATC
azithromycin; systemic
1.1
9.2
5732
45069
HAD40
NOMESCO Finland
Mastopexy
6.3
9.2
24
32
D77
ICPC
Malignant digestive neopl other/NOS
33.6
9.1
12
*
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.2
9.1
1423
10088
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
2.5
9.1
72
247
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.0
9.1
119
513
H00.1
ICD-10 Finland
Chalazion
1.5
9.1
271
1491
5702
FHL
Local lymph node removal (eg armpit, groin)
11.0
9.1
17
13
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
3.6
9.0
40
94
H91.1
ICD-10 Finland
Presbycusis
1.5
9.0
322
1843
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
1.5
9.0
291
1630
N18.8
ICD-10 Finland
Other chronic renal failure
1.7
9.0
178
879
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
7.3
9.0
21
24
ENA10
NOMESCO Finland
Biopsy of pharynx
4.2
8.9
33
66
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.3
8.9
890
6010
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
14.0
8.9
15
9
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
2.9
8.9
53
155
Z93.2
ICD-10 Finland
Ileostomy status
4.6
8.9
30
55
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.4
8.8
383
2280
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.2
8.8
1418
10077
Z94.4
ICD-10 Finland
Liver transplant status
3.7
8.8
37
83
HA1BA
NOMESCO Finland
Extensive X-ray mammography
3.5
8.8
40
96
B05DB
ATC
Hypertonic solutions
2.8
8.8
56
170
N07BB01
ATC
disulfiram; oral
0.6
8.8
156
2088
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.4
8.8
368
2178
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
8.8
9
*
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
+∞
8.8
9
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
8.8
9
*
L01XE11
ATC
[U] pazopanib; oral
+∞
8.8
9
*
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
+∞
8.8
9
*
C739
ICD-10 Finland
NA
+∞
8.8
9
*
L01XE04
ATC
[U] sunitinib; oral
+∞
8.8
9
*
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
+∞
8.8
9
*
8520/3-C50.2
ICD-O-3
Lobular carcinoma, NOS, of upper-inner quadrant of breast
+∞
8.8
9
*
C44.89
ICD-10 Finland
Overall malignant tumor of the skin other or unspecified histology
+∞
8.8
9
*
198
Kela drug reimbursment
Sorafenib
+∞
8.8
9
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
+∞
8.8
9
*
C16.09
ICD-10 Finland
Malignant tumor of cardiac or other unspecified carcinoma
+∞
8.8
9
*
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
+∞
8.8
9
*
9700/3-C44.7
ICD-O-3
Mycosis fungoides of skin of lower limb and hip
+∞
8.8
9
*
C80.91
ICD-10 Finland
Malignant tumor without specified localization epidermoid carcinoma
+∞
8.8
9
*
C49.10
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder without histology
+∞
8.8
9
*
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
+∞
8.8
9
*
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
+∞
8.8
9
*
C44.09
ICD-10 Finland
Malignant tumor of the lip skin other or unspecified histology
+∞
8.8
9
*
C34.02
ICD-10 Finland
Malignant tumor of the main bronchial adenocarcinoma
+∞
8.8
9
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
8.8
9
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
8.8
9
*
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
+∞
8.8
9
*
8520/2-C50.9
ICD-O-3
Lobular carcinoma in situ, NOS, of breast, NOS
+∞
8.8
9
*
C18.50
ICD-10 Finland
Malignant tumor in flexural lienalis without histology
+∞
8.8
9
*
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
+∞
8.8
9
*
C18.30
ICD-10 Finland
Malignant tumor of flexura hepatica without histology
+∞
8.8
9
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
8.8
9
*
8097/3-C44.4
ICD-O-3
Basal cell carcinoma, nodular of skin of scalp and neck
+∞
8.8
9
*
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
8.8
9
*
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
+∞
8.8
9
*
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
+∞
8.8
9
*
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
+∞
8.8
9
*
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
8.8
9
*
8310/3-C56.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of ovary
+∞
8.8
9
*
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
+∞
8.8
9
*
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
+∞
8.8
9
*
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
84.0
8.7
10
*
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
84.0
8.7
10
*
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
84.0
8.7
10
*
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
3.7
8.7
37
84
KE1CG
NOMESCO Finland
Extensive MRI of prostate
5.5
8.7
25
38
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
5.0
8.7
27
45
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
3.0
8.7
50
142
XQ902
NOMESCO Finland
Other photography
3.1
8.7
47
129
D02AE01
ATC
carbamide; topical
1.3
8.7
541
3427
J01FF01
ATC
clindamycin; systemic
1.2
8.6
2485
18556
1XX32
NOMESCO Finland
NA
25.2
8.6
12
*
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
25.2
8.6
12
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.2
8.6
1462
10446
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.3
8.6
563
3593
QXE99
NOMESCO Finland
Other excision or repair of unspecified region of skin
8.0
8.6
19
20
ELB50
NOMESCO Finland
Total parotidectomy
6.4
8.6
22
29
HA1SA
NOMESCO Finland
Expansion mammography
7.3
8.5
20
23
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.2
8.5
1324
9381
SPAT1147
SPAT
Destruction of skin lesion with external methods
1.8
8.5
147
698
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.0
8.4
107
455
SPAT1301
SPAT
No procedures
1.1
8.4
2772
20889
XCK10
NOMESCO Finland
Photography of fundus of eye
1.3
8.4
809
5440
LFC00
NOMESCO Finland
Partial excision of vulva
5.9
8.4
23
33
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
6.2
8.4
22
30
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
10.3
8.3
16
13
D18
ICPC
Change in faeces/bowel movements
1.8
8.3
147
701
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
3.2
8.3
42
110
-
ICD-10 Finland
NA
1.6
8.3
200
1044
D07AC13
ATC
mometasone; topical
1.1
8.3
2672
20107
L21.0
ICD-10 Finland
Seborrhoea capitis
2.2
8.3
83
321
X26
ICPC
Fear of breast cancer female
3.1
8.2
44
120
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.4
8.2
348
2065
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
4.4
8.2
29
56
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
3.2
8.2
41
107
J01AA04
ATC
lymecycline; systemic
1.2
8.1
999
6906
HA4ST
NOMESCO Finland
Labeling mammary gland pathology with sterotactic guidance
8.0
8.1
18
19
N95.0
ICD-10 Finland
Postmenopausal bleeding
1.3
8.1
726
4837
EBA00
NOMESCO Finland
Extraction of tooth
0.9
8.1
2383
22280
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
1.5
8.0
303
1757
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
2.9
8.0
47
136
UDC00
NOMESCO Finland
Ear microscopy
1.3
8.0
559
3601
G03DA02
ATC
medroxyprogesterone; systemic (pregnen (4) derivatives)
1.2
8.0
926
6363
A02BA02
ATC
ranitidine; systemic
1.2
8.0
1782
13031
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
2.3
8.0
73
269
T71
ICPC
Malignant neoplasm thyroid
42.0
8.0
10
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.4
8.0
335
1985
Z94.1
ICD-10 Finland
Heart transplant status
4.1
7.9
30
62
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
1.6
7.9
204
1086
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
2.8
7.9
50
151
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
2.9
7.9
47
138
L04AA05
ATC
[U] tacrolimus; systemic
6.9
7.9
19
23
SPAT1109
SPAT
Analgesia with portable analgesic pump
5.4
7.9
23
36
XF600
NOMESCO Finland
Bloodpressure measurement
1.4
7.8
431
2677
21899
ICD-8 Finland
Uterine fibroma
1.5
7.8
258
1453
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
1.7
7.8
141
681
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
75.6
7.8
9
*
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
75.6
7.8
9
*
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
75.6
7.8
9
*
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
75.6
7.8
9
*
B01AA03
ATC
warfarin; systemic
1.2
7.8
1423
10233
C49.99
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue other or unspecified tumor
+∞
7.8
8
*
C50.5
ICD-10 Finland
Malignant neoplasm: Lower-outer quadrant of breast
+∞
7.8
8
*
C18.60
ICD-10 Finland
Malignant tumor of the descending colon without histology
+∞
7.8
8
*
8441/3-C56.9
ICD-O-3
Serous carcinoma, NOS, of ovary
+∞
7.8
8
*
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
+∞
7.8
8
*
8520/3-C50.5
ICD-O-3
Lobular carcinoma, NOS, of lower-outer quadrant of breast
+∞
7.8
8
*
1CD01
NOMESCO Finland
NA
+∞
7.8
8
*
C18.49
ICD-10 Finland
Malignant tumor of the transverse colon other or unspecified histology
+∞
7.8
8
*
C67
ICD-10 Finland
Malignant neoplasm of bladder
+∞
7.8
8
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
7.8
8
*
C49.49
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor
+∞
7.8
8
*
1731A
ICD-9 Finland
Other malignant neoplasm of skin, Eyelid, including canthus[LUOMEN IHON SYÖPÄ,CA BASOCELLULARE]
+∞
7.8
8
*
C18.22
ICD-10 Finland
Malignant tumor of the colon ascending carcinoma of the adenoma
+∞
7.8
8
*
B72
ICPC
Hodgkin Lymphoma
+∞
7.8
8
*
EJB40
NOMESCO Finland
Hemiglossectomy
+∞
7.8
8
*
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
+∞
7.8
8
*
8070/3-C21.0
ICD-O-3
Squamous cell carcinoma, NOS, of anus, NOS
+∞
7.8
8
*
ZZS55
NOMESCO Finland
Distension of tissue expander
+∞
7.8
8
*
18099
ICD-8 Finland
Malignant neoplasm of cervix uteri
+∞
7.8
8
*
399
Kela drug reimbursment
Venetoclax
+∞
7.8
8
*
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
+∞
7.8
8
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
7.8
8
*
C49.39
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor
+∞
7.8
8
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
7.8
8
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
7.8
8
*
C82.7
ICD-10 Finland
Other types of follicular lymphoma
+∞
7.8
8
*
L01XE33
ATC
[U] palbociclib; oral
+∞
7.8
8
*
C69.32
ICD-10 Finland
Malignant tumor of the chorioidea melanoma
+∞
7.8
8
*
20298
ICD-8 Finland
Other neoplasms of lymphoid tissue, Lymphomata alia
+∞
7.8
8
*
L01BC59
ATC
trifluridine, combinations; systemic
+∞
7.8
8
*
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
+∞
7.8
8
*
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
9.0
7.8
16
15
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
2.7
7.8
50
154
40399
ICD-8 Finland
Hypertensive renal disease
4.8
7.8
25
44
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
23.1
7.7
11
*
1CX01
NOMESCO Finland
NA
6.2
7.7
20
27
ZXC12
NOMESCO Finland
Pulse colorlaser
3.8
7.7
31
68
4056
NOMESCO Finland
NA
6.6
7.7
19
24
D02AX
ATC
Other emollients and protectives
1.5
7.7
223
1221
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.2
7.7
1131
7968
R84
ICPC
Malignant neoplasm bronchus/lung
16.8
7.7
12
6
G03FB06
ATC
medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
1.2
7.7
929
6415
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
2.1
7.7
88
361
SPAT1283
SPAT
Restricted health certificate
0.8
7.6
678
7023
C02EA02
ATC
NA
1.5
7.6
290
1686
SPAT1361
SPAT
Collection of tissue sample
2.7
7.6
50
157
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.2
7.6
992
6909
D01BA02
ATC
terbinafine; oral; topical
1.1
7.6
2432
18279
R22.7
ICD-10 Finland
Localized swelling, mass and lump, multiple sites
5.1
7.6
23
38
D64.9
ICD-10 Finland
Anaemia, unspecified
1.3
7.5
602
3952
Z43.3
ICD-10 Finland
Attention to colostomy
8.4
7.5
16
16
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.3
7.5
510
3274
QCA50
NOMESCO Finland
Cryotherapy of skin of upper limb
6.4
7.5
19
25
H61.2
ICD-10 Finland
Impacted cerumen
1.4
7.5
432
2706
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
4.6
7.5
25
46
Z40.0
ICD-10 Finland
Prophylactic surgery for risk-factors related to malignant neoplasms
10.7
7.5
14
11
L21
ICD-10 Finland
Seborrhoeic dermatitis
1.9
7.4
106
475
JFF10
NOMESCO Finland
Loop enterostomy
4.1
7.4
28
58
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
3.1
7.4
39
106
ZZG00
NOMESCO Finland
Graft of cartilage
5.5
7.4
21
32
N05AX08
ATC
risperidone; systemic
0.7
7.4
277
3218
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
3.2
7.4
37
97
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
1.4
7.4
328
1965
H00.00
ICD-10 Finland
Hordeolum
1.4
7.4
283
1649
J01CA04
ATC
amoxicillin; systemic
1.1
7.4
8278
66919
N64.9
ICD-10 Finland
Disorder of breast, unspecified
2.3
7.4
64
233
H04.10
ICD-10 Finland
Dry eye syndrome
1.2
7.3
855
5880
6500B
ICD-9 Finland
Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]
0.8
7.3
1093
10771
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
14.4
7.3
12
7
5850B
ICD-9 Finland
Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA CUM URAEMIA]
18.5
7.3
11
5
XCD10
NOMESCO Finland
Electrophysiological examination of eye
1.6
7.3
160
820
9733
FHL
Excision of skin change in operating room or anesthesia
1.9
7.2
104
466
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
5.3
7.2
21
33
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
3.7
7.2
30
68
KFC00
NOMESCO Finland
Unilateral orchiectomy
4.4
7.2
25
48
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.4
7.2
339
2054
OAB42
NOMESCO Finland
Guidance related to known health problem
5.6
7.2
20
30
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
2.9
7.1
41
118
196
Kela drug reimbursment
Paricalcitol and cinacalcet
2.8
7.1
45
136
ZZS40
NOMESCO Finland
V-Y or Y-V advancement flap
37.8
7.1
9
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.2
7.0
949
6631
ZXC10
NOMESCO Finland
Use of laser
1.6
7.0
167
873
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.2
7.0
1879
13935
N64.5
ICD-10 Finland
Other signs and symptoms in breast
1.7
7.0
142
711
C02DE10
ATC
NA
2.2
7.0
69
266
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
1.8
7.0
106
486
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
1.8
7.0
115
541
D18.0
ICD-10 Finland
Haemangioma, any site
1.6
7.0
173
915
KBV10
NOMESCO Finland
Removal of stent from ureter
2.5
7.0
52
175
L56.8
ICD-10 Finland
Other specified acute skin changes due to ultraviolet radiation
4.4
6.9
24
46
5602
FHL
Internal fistula (eg Cimino)
12.6
6.9
12
8
L98.69
ICD-10 Finland
Other infiltrative disease of the skin and subcutaneous tissue
12.6
6.9
12
8
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
2.8
6.9
41
121
H13
ICPC
Plugged feeling ear
1.2
6.9
1517
11077
YNB10
NOMESCO Finland
Collection of stem cells for transplant
21.0
6.9
10
*
9703
FHL
Breast resection
2.4
6.9
55
192
R06AE07
ATC
cetirizine; oral
1.1
6.9
4004
31188
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.2
6.9
970
6806
Z49.2
ICD-10 Finland
Other dialysis
2.3
6.9
61
225
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
6.0
6.9
18
25
M05BA02
ATC
clodronic acid; systemic
15.4
6.9
11
6
C43.51
ICD-10 Finland
Malignant melanoma of the trunk originating in lentigo maligna
67.2
6.9
8
*
G04BE30
ATC
drugs used in erectile dysfunction - combinations
67.2
6.9
8
*
D74
ICPC
Malignant neoplasm stomach
67.2
6.9
8
*
C44.6
ICD-10 Finland
Malignant neoplasm: Skin of upper limb, including shoulder
67.2
6.9
8
*
WXQ40
NOMESCO Finland
Photodynamic therapy of broad area
67.2
6.9
8
*
C02.2
ICD-10 Finland
Malignant neoplasm: Ventral surface of tongue
67.2
6.9
8
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
67.2
6.9
8
*
7158
FHL
Graft removal
67.2
6.9
8
*
C43.30
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face without histology
67.2
6.9
8
*
N30.4
ICD-10 Finland
Irradiation cystitis
67.2
6.9
8
*
C10AA04
ATC
fluvastatin; oral
1.3
6.8
703
4765
5828A
ICD-9 Finland
Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]
6.5
6.8
17
22
H02AB09
ATC
hydrocortisone; systemic
1.7
6.8
144
731
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
4.0
6.8
26
55
L01XX52
ATC
venetoclax; oral
+∞
6.8
7
*
8070/3-C02.9
ICD-O-3
Squamous cell carcinoma, NOS, of tongue, NOS
+∞
6.8
7
*
1743A
ICD-9 Finland
Malignant neoplasm of female breast, Lower-inner quadrant
+∞
6.8
7
*
C51.9
ICD-10 Finland
Malignant neoplasm: Vulva, unspecified
+∞
6.8
7
*
341
Kela drug reimbursment
Afatinib and gefitinib
+∞
6.8
7
*
JN4LR
NOMESCO Finland
Extensive PET-CT of receptors in whole body
+∞
6.8
7
*
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
+∞
6.8
7
*
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
+∞
6.8
7
*
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
6.8
7
*
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
+∞
6.8
7
*
C18
ICD-10 Finland
Malignant neoplasm of colon
+∞
6.8
7
*
C50.3
ICD-10 Finland
Malignant neoplasm: Lower-inner quadrant of breast
+∞
6.8
7
*
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
+∞
6.8
7
*
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
+∞
6.8
7
*
1BA04
NOMESCO Finland
NA
+∞
6.8
7
*
8542/3-C44.5
ICD-O-3
Paget disease, extramammary of skin of trunk
+∞
6.8
7
*
JJB71
NOMESCO Finland
Laparoscopic resection of liver
+∞
6.8
7
*
L01EX07
ATC
cabozantinib; oral
+∞
6.8
7
*
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
+∞
6.8
7
*
C18.9
ICD-10 Finland
Malignant neoplasm: Colon, unspecified
+∞
6.8
7
*
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
+∞
6.8
7
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
6.8
7
*
C84.43
ICD-10 Finland
Peripheral T-cell lymphoma, large cell type
+∞
6.8
7
*
C84.1
ICD-10 Finland
Sézary disease
+∞
6.8
7
*
C18.11
ICD-10 Finland
Malignant tumor of the appendix invasive carcinoma
+∞
6.8
7
*
L01XE13
ATC
[U] afatinib; oral
+∞
6.8
7
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
6.8
7
*
C43.42
ICD-10 Finland
Malignant melanoma of the scalp and neck: 'superficial spreading' type
+∞
6.8
7
*
9140/3-C44.7
ICD-O-3
Kaposi sarcoma of skin of lower limb and hip
+∞
6.8
7
*
C441, 8097, 3
ICD-O-3
NA
+∞
6.8
7
*
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
+∞
6.8
7
*
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
+∞
6.8
7
*
8070/3-C80.9
ICD-O-3
Squamous cell carcinoma, NOS, of unknown primary site
+∞
6.8
7
*
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
+∞
6.8
7
*
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
+∞
6.8
7
*
C34.86
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
+∞
6.8
7
*
322
Kela drug reimbursment
Sunitinib
+∞
6.8
7
*
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
6.8
7
*
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
+∞
6.8
7
*
C60.1
ICD-10 Finland
Malignant neoplasm: Glans penis
+∞
6.8
7
*
C44.80
ICD-10 Finland
Overall malignant tumor of the skin without histology
+∞
6.8
7
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
6.8
7
*
C51.81
ICD-10 Finland
Squamous cell carcinoma of the vulva
+∞
6.8
7
*
8832/3-C44.9
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin, NOS
+∞
6.8
7
*
8093/3-C44.9
ICD-O-3
Basal cell carcinoma, fibroepithelial of skin, NOS
+∞
6.8
7
*
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
+∞
6.8
7
*
8130/3-C67.9
ICD-O-3
Papillary urothelial carcinoma of bladder, NOS
+∞
6.8
7
*
1XX25
NOMESCO Finland
NA
+∞
6.8
7
*
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
+∞
6.8
7
*
L02BA02
ATC
toremifene; oral
+∞
6.8
7
*
C44.2
ICD-10 Finland
Malignant neoplasm: Skin of ear and external auricular canal
+∞
6.8
7
*
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
+∞
6.8
7
*
C51.01
ICD-10 Finland
Squamous cell carcinoma of the labium majus
+∞
6.8
7
*
C16.23
ICD-10 Finland
Malignant tumor of the corpus ventriculi diffuse carcinoma
+∞
6.8
7
*
C45.0
ICD-10 Finland
Mesothelioma of pleura
+∞
6.8
7
*
DHB01
NOMESCO Finland
Partial excision of external nose
+∞
6.8
7
*
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
+∞
6.8
7
*
C34.22
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma
+∞
6.8
7
*
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
1.7
6.8
137
687
Z01.8
ICD-10 Finland
Other specified special examinations
1.2
6.8
1878
13957
A10BA02
ATC
metformin; oral
0.9
6.8
2126
19825
J01CA08
ATC
pivmecillinam; oral
1.1
6.8
3554
27517
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
3.6
6.8
29
68
-56
ICPC
Dressing/pressure/compress/tamponade
1.7
6.8
119
573
JFB53
NOMESCO Finland
Resection of sigmoid colon with partial proctectomy
9.9
6.7
13
11
JAH00
NOMESCO Finland
Laparotomy
1.7
6.7
136
680
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.5
6.7
233
1332
G04BD12
ATC
mirabegron; oral
1.2
6.7
812
5606
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
1.6
6.7
166
879
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
2.5
6.7
50
167
QDA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of lower limb
4.4
6.7
23
44
N30.9
ICD-10 Finland
Cystitis, unspecified
1.4
6.7
360
2231
8306
FHL
Hysterectomy (related to abortion 8516, prolapse correction 8436)
1.4
6.7
368
2292
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
2.6
6.7
47
154
HA1DA
NOMESCO Finland
Restricted mammography
8.4
6.6
14
14
F20.9
ICD-10 Finland
Schizophrenia, unspecified
0.5
6.6
50
834
M01AX05
ATC
glucosamine; oral
1.1
6.6
2045
15316
JFF11
NOMESCO Finland
Laparoscopic loop enterostomy
7.4
6.6
15
17
BAA60
NOMESCO Finland
Total thyroidectomy
1.6
6.6
147
758
-44
ICPC
Preventive immunization/medic
1.3
6.6
603
4035
-60
ICPC
Result test/procedure
1.3
6.6
433
2772
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.2
6.6
679
4609
HAD99
NOMESCO Finland
Other plastic operation on breast
4.1
6.6
24
49
R07.4
ICD-10 Finland
Chest pain, unspecified
1.1
6.6
2577
19607
A59
ICPC
General and Unspecified, Other therap proced/minor surg NEC
2.2
6.5
66
258
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
25.2
6.5
9
*
DLD35
NOMESCO Finland
Partial constuction of nose
25.2
6.5
9
*
C07AG02
ATC
carvedilol; oral
1.3
6.5
468
3030
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.4
6.5
280
1669
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
4.9
6.5
20
34
JGB31
NOMESCO Finland
Laparoscopic and perineal excision of rectum
13.2
6.5
11
7
H53.1
ICD-10 Finland
Subjective visual disturbances
1.3
6.5
499
3265
E66.01
ICD-10 Finland
Obesity due to excess calories
0.8
6.5
374
4079
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
2.4
6.5
52
182
D24
ICD-10 Finland
Benign neoplasm of breast
1.7
6.5
123
604
A97
ICPC
No disease
1.2
6.4
1148
8236
R05FA02
ATC
opium derivatives and expectorants; systemic
1.1
6.4
3960
30910
A01AB09
ATC
miconazole; local oral
1.2
6.4
698
4763
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
5.1
6.4
19
31
JFB44
NOMESCO Finland
Laparoscopic left hemicolectomy
5.1
6.4
19
31
D10BA01
ATC
isotretinoin; oral
1.4
6.4
273
1627
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
1.9
6.4
89
396
7531A
ICD-9 Finland
Congenital anomalies of urinary system, Cystic kidney disease
7.0
6.4
15
18
P15
ICPC
Chronic alcohol abuse
0.6
6.4
80
1159
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
5.4
6.3
18
28
E000007
ATC
NA
1.3
6.3
394
2500
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
1.6
6.3
160
851
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
1.3
6.3
386
2445
A09AA02
ATC
multienzymes (lipase, protease etc.)
1.8
6.3
106
504
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
4.3
6.3
22
43
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
10.1
6.3
12
10
Z01.2
ICD-10 Finland
Dental examination
1.1
6.3
3811
29716
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
5.7
6.3
17
25
J01MA06
ATC
norfloxacin; oral
1.2
6.3
1166
8395
JJC00
NOMESCO Finland
Allogenic transplantation of liver
3.6
6.2
26
60
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.3
6.2
560
3742
ZX022
NOMESCO Finland
LDR radiotherapy within tissue
33.5
6.2
8
*
KAC20
NOMESCO Finland
Nephroureterectomy
33.5
6.2
8
*
L72.0
ICD-10 Finland
Epidermal cyst
1.9
6.2
82
360
WVA20
NOMESCO Finland
Medicine administration
1.6
6.2
136
698
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.2
6.2
832
5811
XF404
NOMESCO Finland
Ambulatory ECG
1.2
6.2
761
5267
SPAT1260
SPAT
Consultation of another employee
1.2
6.2
1532
11289
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
2.8
6.2
37
111
C07AB03
ATC
atenolol; systemic
1.3
6.2
421
2712
C10AA03
ATC
pravastatin; oral
1.3
6.2
582
3910
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.3
6.2
534
3550
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
2.1
6.1
64
256
103
Kela drug reimbursment
Diabetes, insulin-treated
0.9
6.1
2032
18899
NF1AA
NOMESCO Finland
Hip X-ray examination
1.2
6.1
671
4586
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
2.7
6.1
40
126
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
4.5
6.1
20
37
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.3
6.1
361
2277
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
18.9
6.1
9
*
L01AA03
ATC
melphalan; systemic
18.9
6.1
9
*
KCC10
NOMESCO Finland
Cystoprostatectomy
18.9
6.1
9
*
N05AA02
ATC
levomepromazine; systemic
0.7
6.1
173
2099
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
2.1
6.1
67
272
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
3.9
6.1
23
49
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
2.3
6.0
52
189
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.1
6.0
2812
21597
D07AD01
ATC
clobetasol; topical
1.2
6.0
1431
10510
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.5
6.0
227
1320
F10.25
ICD-10 Finland
Alcohol dependence continuous use
0.5
6.0
44
739
N05AH03
ATC
olanzapine; systemic
0.7
6.0
225
2612
B74
ICPC
Malignant neoplasm blood other
9.2
6.0
12
11
Z72.0
ICD-10 Finland
Tobacco use
0.6
6.0
75
1084

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
382
209
12.71
312.87
2.6
1.1
u/ml
31.4
29.1
0.09
370
192
(40768443) Skin Pathology biopsy report
2279
5592
2.98
307.65
1.3
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
7449
10557
6.50
307.65
1.5
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
15526
43366
4.94
307.65
3.1
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2795
7568
2.73
307.65
3.7
1.5
ug/l
13.5
10.0
0.54
2267
5708
(4035726)
2694
3961
5.11
307.65
1.4
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
12337
64718
1.62
271.22
6.3
3.8
umol/l
12.0
11.9
0.41
11617
60368
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
17718
101975
1.68
265.72
8.3
5.5
u/l
79.9
76.2
14.85
16493
94021
(3024561) Albumin [Mass/volume] in Serum or Plasma
11001
56316
1.61
265.05
5.2
3.8
g/l
34.9
35.5
25.27
10079
51254
(3013650) Neutrophils [#/volume] in Blood by Automated count
13147
70429
1.60
260.78
9.5
6.4
e9/l
4.2
4.3
6.14
11431
60008
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
3494
13066
1.97
249.45
4.4
2.7
u/l
243.9
241.7
0.41
3305
12086
(3015377) Calcium [Moles/volume] in Serum or Plasma
8626
42398
1.61
237.87
3.4
2.1
mmol/l
2.4
2.4
0.26
7308
35074
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
12611
68079
1.55
229.15
7.4
5.7
mmol/l
1.2
1.2
0.23
10547
57058
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
11582
61546
1.55
223.71
6.5
5.3
mmol/l
1.2
1.2
0.22
10345
54370
(40768800) Prostate Pathology biopsy report
592
881
4.70
219.85
1.2
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
160
18
61.33
207.41
1.1
1.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
7596
37215
1.58
204.72
2.7
2.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
10696
56561
1.52
204.59
4.3
3.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
15428
88590
1.52
196.13
5.3
4.5
e6/l
997.0
1596.9
0.93
190
1335
(3023368) Bacteria identified in Blood by Culture
7216
35237
1.57
195.20
4.7
3.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
10516
56456
1.48
178.49
11.1
9.9
inr
1.3
1.3
0.81
2907
15471
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
235
148
10.98
177.99
3.0
1.1
u/ml
43.6
22.0
1.41
229
137
(40768793) Breast Pathology biopsy report
506
804
4.38
173.94
1.3
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
7336
36883
1.52
168.50
3.6
3.0
e6/l
0.4
0.4
0.52
5629
27457
(3018418) pH of Serum or Plasma
7774
39619
1.50
167.11
4.9
3.3
ph
7.4
7.4
0.70
1433
6839
(40758558) Short blood count panel - Blood
6149
29858
1.55
164.95
7.4
4.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
7808
40050
1.49
161.29
3.8
3.1
e6/l
95.7
93.9
0.03
6049
30343
(36304419) Bacteria [Presence] in Urine
7042
35407
1.51
159.85
3.6
2.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
5901
28570
1.55
159.42
2.6
2.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
240
186
8.92
159.38
1.2
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
8873
46963
1.46
154.87
4.3
3.5
e6/l
104.1
114.6
0.47
6483
32905
(40768795) Lymph node Pathology biopsy report
274
273
6.95
150.46
1.2
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
8274
43427
1.46
149.33
6.6
5.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
11516
64454
1.42
145.82
6.6
5.5
e9/l
0.0
0.0
4.90
9874
54974
(3001604) Monocytes [#/volume] in Blood
11456
64067
1.42
145.63
6.5
5.4
e9/l
0.6
0.6
0.63
9810
54607
(3019198) Lymphocytes [#/volume] in Blood
11682
65735
1.42
142.07
6.6
5.5
e9/l
2.0
1.9
3.63
10172
57106
(3013826) Glucose [Moles/volume] in Serum or Plasma
13775
79831
1.42
141.45
4.9
4.4
mmol/l
6.8
6.8
4.28
13036
74390
(3013115) Eosinophils [#/volume] in Blood
11801
66575
1.41
141.03
6.8
5.6
e9/l
0.2
0.2
9.35
10264
57634
(3000850) Epithelial cells [#/volume] in Urine
5671
27862
1.51
140.13
2.9
2.5
e6/l
4.5
5.2
4.20
4923
24059
(3033658) Prothrombin time (PT) actual/Normal
6246
31350
1.49
139.05
4.3
3.6
%
85.4
87.6
8.66
6114
30477
(3026782) Osmolality of Urine
5298
25737
1.52
137.63
3.2
2.7
mosm/kgh2o
544.1
542.8
0.16
4492
21457
(3019069) Monocytes/100 leukocytes in Blood
10712
59665
1.41
135.71
7.2
6.0
%
8.9
8.7
3.79
9904
55036
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
5039
24307
1.53
134.82
3.2
2.2
mmol/l
2.5
2.5
6.79
4359
20641
(3022096) Basophils/100 leukocytes in Blood
10396
57702
1.41
133.68
7.0
5.7
%
0.7
0.7
4.11
9584
53031
(3006504) Eosinophils/100 leukocytes in Blood
10650
59377
1.40
133.33
6.9
5.7
%
2.8
3.0
13.61
9821
54523
(3002030) Lymphocytes/100 leukocytes in Blood
10873
60984
1.40
130.42
7.1
5.8
%
26.8
27.5
6.27
10007
55901
(3027945) Reticulocytes/100 erythrocytes in Blood
3439
15321
1.63
128.82
2.6
2.2
%
1.8
1.8
0.00
2983
13257
(3018010) Neutrophils/100 leukocytes in Blood
10725
60273
1.39
125.31
6.8
5.6
%
58.2
57.6
5.08
9901
55543
(3037467) Urinalysis macro (dipstick) panel - Urine
15612
93410
1.40
125.09
5.1
4.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
4139
19404
1.56
124.70
3.3
2.5
mmol/l
0.8
0.8
3.08
3802
17672
(3026008) Bacteria identified in Urine by Culture
7871
42125
1.41
121.14
3.6
3.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
952
2802
2.38
120.59
3.1
2.0
u/ml
3271.3
131.2
0.60
808
2267
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
20956
132836
1.55
119.71
18.4
13.4
mg/l
26.0
23.7
14.90
17046
104074
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
6580
34269
1.43
116.96
2.4
2.3
mg/l
3.1
3.0
3.62
5550
28942
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
2383
9993
1.70
111.38
2.3
2.1
g/l
0.2
0.2
0.06
2200
9038
(3023520) Reticulocytes [#/volume] in Blood
2655
11467
1.66
111.09
2.7
2.2
e9/l
68.2
69.4
0.96
2020
8721
(3003458) Phosphate [Moles/volume] in Serum or Plasma
3557
16717
1.54
103.99
7.2
5.4
mmol/l
1.0
1.0
0.48
3269
15336
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
8264
45518
1.37
102.60
3.2
3.0
ng/l
1861.8
1506.9
7.53
7136
39026
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
8733
48541
1.36
102.27
5.8
3.9
ug/l
3.3
2.3
4.24
7650
43457
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
4389
21677
1.47
100.76
2.0
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
10085
57427
1.35
100.30
11.5
8.7
e9/l
0.0
0.0
0.02
8288
46962
(3049717) Cytology report of Urine Cyto stain
1288
4613
1.96
99.72
2.7
1.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
21963
141808
1.58
98.68
21.7
16.2
mmol/l
139.7
139.8
13.20
21448
137755
(3007853) Bacteria identified in Skin by Aerobe culture
3262
15219
1.54
98.06
1.9
1.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
4617
23151
1.45
97.63
3.1
2.6
e6/l
1.1
1.2
0.57
2712
13377
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
4239
20910
1.47
97.54
3.3
2.7
e6/l
2.2
2.9
3.72
2364
11238
(3023103) Potassium [Moles/volume] in Serum or Plasma
21989
142149
1.57
96.06
22.0
16.3
mmol/l
4.0
4.0
0.79
21442
137856
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
111
61
12.53
90.71
1.3
1.1
ug/l
1.9
2.8
0.49
57
30
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
655
1852
2.46
90.26
1.3
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
3707
18129
1.47
88.11
3.0
2.6
%
21.6
22.4
3.10
3168
15133
(3013707) Erythrocyte sedimentation rate by Westergren method
16499
101953
1.33
87.38
4.5
4.2
mm/h
13.9
12.6
20.22
14983
93518
(3004789) Transferrin [Mass/volume] in Serum or Plasma
3916
19408
1.46
86.78
2.9
2.5
g/l
2.3
2.3
7.65
3594
17722
(3022948) Iron [Moles/volume] in Serum or Plasma
4198
21108
1.44
86.10
2.9
2.5
umol/l
12.1
12.8
8.05
3848
19269
(3014576) Chloride [Moles/volume] in Serum or Plasma
3390
16455
1.48
83.21
6.6
6.6
mmol/l
104.5
104.2
2.01
3331
16025
(3042936) Bacteria identified in Isolate by Culture
3636
17909
1.46
82.81
2.1
2.1
—
—
—
0
0
(3044889) 12 lead EKG panel
15844
97660
1.32
82.60
4.5
4.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
10616
62001
1.31
82.53
2.2
2.0
pmol/l
95.2
95.5
0.23
5394
31114
(3001122) Ferritin [Mass/volume] in Serum or Plasma
9164
52525
1.31
81.36
3.1
2.8
ug/l
154.2
133.0
7.80
8256
47843
(3020564) Creatinine [Moles/volume] in Serum or Plasma
21988
142938
1.51
81.10
21.8
15.6
umol/l
84.5
79.4
56.13
21976
142875
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
5134
26985
1.38
81.08
3.5
2.8
ug/l
0.8
0.7
6.82
3728
18641
(3020779) Urea [Moles/volume] in Serum or Plasma
2518
11547
1.55
80.62
8.7
7.0
mmol/l
11.3
10.8
2.30
2377
10902
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
21960
142831
1.50
79.06
12.3
9.4
u/l
24.5
25.5
8.33
20961
136278
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
19863
126926
1.38
78.08
17.6
12.4
ml/min/173m2
72.4
76.1
119.64
16754
102076
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
128
112
7.87
78.02
5.5
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
21300
137797
1.44
77.58
17.3
13.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
6969
38707
1.33
76.03
4.9
3.8
%
22.2
24.1
20.87
3754
18918
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
9696
56412
1.29
75.04
2.3
2.2
nmol/l
81.8
79.2
14.93
8442
49329
(3020630) Protein [Mass/volume] in Serum or Plasma
2458
11409
1.53
74.15
2.8
1.6
g/l
65.9
66.8
6.83
2207
10153
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
565
1638
2.40
73.79
2.8
1.9
u/ml
739.0
691.1
0.03
507
1471
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
2814
13482
1.49
72.92
3.8
3.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
3072
15048
1.46
71.00
1.9
1.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
1503
6275
1.68
70.10
1.7
1.6
g/l
1.5
1.6
2.18
1285
5320
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
2033
9160
1.57
69.81
1.7
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
6287
34763
1.32
69.42
1.6
1.5
nmol/l
21.0
20.6
0.84
5253
29205
(3019309) Folate [Moles/volume] in Red Blood Cells
5434
29429
1.34
69.16
1.8
1.8
nmol/l
1176.4
1164.4
0.40
3970
21946
(3010375) cycloSPORINE [Mass/volume] in Blood
249
471
3.65
68.38
32.0
27.8
ug/l
96.6
114.8
5.51
225
390
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
84
47
12.29
68.02
1.1
1.1
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
278
574
3.35
67.19
2.0
2.1
%
35.7
44.3
1.88
29
88
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
3044
15057
1.44
66.47
1.9
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
2289
10700
1.51
66.41
7.3
8.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
22465
147568
1.50
65.64
27.5
19.9
g/l
132.7
135.7
164.50
22107
144670
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
314
711
3.05
65.56
1.7
1.3
ug/l
24.6
23.9
0.05
308
689
(3024731) MCV [Entitic volume]
22461
147545
1.50
65.49
27.3
19.7
fl
91.8
91.5
28.81
22108
144631
(3035941) MCH [Entitic mass]
22458
147524
1.50
65.44
27.2
19.7
pg
30.5
30.4
2.64
22106
144618
(3026361) Erythrocytes [#/volume] in Blood
22461
147552
1.50
65.37
27.4
19.8
e12/l
4.4
4.5
146.42
21735
141930
(3007461) Platelets [#/volume] in Blood
22452
147483
1.50
65.33
27.4
19.8
e9/l
239.5
246.6
46.99
21813
142490
(3010813) Leukocytes [#/volume] in Blood
22462
147566
1.50
65.26
27.4
19.8
e9/l
6.9
6.7
7.62
21741
141962
(3042111) Morphology [Interpretation] in Bone marrow Narrative
536
1606
2.32
65.08
1.5
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
588
1835
2.23
64.96
6.5
5.8
iu/ml
785.8
959.9
0.14
99
279
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
2299
10813
1.50
64.69
4.3
3.7
ng/l
99.2
92.5
2.08
1958
9111
(3018677) aPTT in Platelet poor plasma by Coagulation assay
3973
20744
1.37
63.22
2.0
1.9
s
30.1
29.9
0.61
3867
20083
(3022217) INR in Platelet poor plasma by Coagulation assay
3945
20588
1.37
62.93
32.1
27.9
inr
1.5
1.4
0.51
438
2758
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
2745
13563
1.44
59.83
3.1
2.2
umol/l
7.7
7.8
0.14
2369
11604
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
473
1397
2.35
59.34
3.0
2.6
u/ml
528.6
7378.7
0.51
31
81
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
675
2315
2.03
58.66
1.5
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
228
452
3.48
58.61
1.8
2.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
291
680
2.96
57.66
2.1
2.1
e9/l
1.2
1.0
0.99
180
362
(3002385) Erythrocyte distribution width [Ratio]
16973
107505
1.27
57.36
22.5
16.0
%
13.9
13.7
39.64
16606
104754
(3014111) Lactate [Moles/volume] in Serum or Plasma
2341
11350
1.46
56.20
6.0
6.8
mmol/l
1.4
1.4
1.06
2255
10913
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
250
543
3.18
55.92
2.4
2.1
e6/l
565.9
923.1
1.18
78
256
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
1034
4143
1.74
55.71
2.6
3.1
u/ml
0.4
0.4
0.43
587
2448
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
9495
56454
1.25
55.70
4.2
3.8
ng/l
81.1
76.1
0.04
7277
40656
(3026493) Urate [Moles/volume] in Serum or Plasma
6551
37406
1.27
53.79
3.2
2.4
umol/l
5508.3
5562.9
0.03
5513
31741
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
2284
11138
1.45
53.03
2.5
2.3
u/l
44.2
42.3
0.07
1955
9384
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1041
4248
1.71
52.53
2.6
2.9
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
228
492
3.20
51.57
1.7
1.9
%
70.4
71.6
0.38
214
466
(3022145) Colonoscopy Study observation
2770
14050
1.40
51.55
1.3
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
340
921
2.55
51.27
1.3
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
1730
8062
1.51
50.34
1.7
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
19328
125001
1.28
50.08
5.0
4.8
mu/l
2.2
2.1
0.37
17263
112987
(3035350) Ketones [Presence] in Urine by Test strip
10962
66720
1.23
49.72
4.3
3.8
estimate
0.0
0.0
0.80
2128
11356
(3009261) Glucose [Presence] in Urine by Test strip
11087
67564
1.23
49.68
4.4
3.8
estimate
0.0
0.0
0.03
2105
11253
(3004588) Protein electrophoresis panel - Serum or Plasma
2059
9970
1.45
49.45
2.6
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
10962
66754
1.23
49.32
5.7
5.1
estimate
0.0
0.0
1.60
2136
11560
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
220
479
3.17
49.08
1.6
1.9
%
14.9
15.8
0.34
109
211
(3003434) Protein [Mass/volume] in Pleural fluid
462
1476
2.17
48.28
1.4
1.5
g/l
31.2
29.8
1.37
407
1294
(3015736) pH of Urine
8751
52135
1.23
48.15
4.0
3.6
ph
6.0
5.3
1.90
12
16
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
190
381
3.44
48.12
2.9
2.5
%
37.3
43.0
1.53
50
139
(3017181) Myelocytes/100 leukocytes in Blood
2130
10450
1.44
47.62
4.4
3.7
%
1.0
0.8
2.27
637
2199
(3027801) Oxygen [Partial pressure] in Arterial blood
2961
15397
1.36
47.02
6.2
7.0
kpa
12.1
11.6
5.75
2815
14643
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
2961
15407
1.36
46.81
6.2
7.0
kpa
5.0
5.1
0.45
2813
14661
(3019420) Tryptase [Mass/volume] in Serum or Plasma
224
512
3.02
46.18
1.2
1.5
ug/l
6.6
9.5
1.92
212
446
(3003396) Base excess in Arterial blood by calculation
2950
15373
1.36
46.14
6.2
7.0
mmol/l
0.9
1.3
6.76
2297
11988
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
741
2851
1.81
45.75
1.7
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
2173
10776
1.42
45.71
4.6
3.0
mmol/l
1.2
1.2
0.04
1867
9066
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
277
719
2.66
45.47
3.1
1.6
nmol/l
9.5
4.4
1.03
269
683
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
237
566
2.89
45.33
1.7
1.4
mg/l
4.2
3.9
0.40
221
538
(3013512) EKG study
7322
43030
1.24
44.92
4.5
4.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
7222
42381
1.24
44.90
2.6
2.3
u/l
60.3
59.9
0.11
6553
38568
(3009542) Hematocrit [Volume Fraction] of Blood
18092
116564
1.24
44.50
20.1
14.9
%
38.8
39.4
10.39
11394
76191
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
92
108
5.86
43.92
1.9
1.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
1709
8170
1.47
43.65
7.6
9.0
%
94.0
93.4
4.67
1702
8144
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
1706
8172
1.46
43.12
7.5
9.0
%
0.7
0.7
2.25
1700
8118
(3021440) Promyelocytes/100 leukocytes in Blood
2032
10072
1.42
42.73
4.4
3.8
%
0.1
0.1
2.34
593
2054
(40768806) Pleura Pathology biopsy report
344
1028
2.31
42.15
1.5
1.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
2428
12497
1.37
40.74
6.8
7.8
g/l
119.7
122.4
8.80
2347
12026
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
20549
134710
1.28
40.67
5.3
5.0
mmol/l
6.0
6.0
5.44
18279
121751
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
994
4291
1.61
40.35
3.6
1.5
u/ml
61.2
28.7
3.33
956
4072
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
739
2957
1.74
39.96
3.6
2.7
mg/l
1.8
1.7
2.10
666
2627
(3016502) Oxygen saturation in Arterial blood
2647
13853
1.35
39.86
6.4
7.3
%
95.5
95.1
2.20
2551
13320
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
1535
7316
1.47
39.72
6.0
7.2
mmol/l
24.7
24.8
0.96
1526
7234
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
4989
28418
1.26
39.54
4.1
4.0
ng/l
316.5
557.8
6.64
4279
23212
(3017446) Testosterone [Moles/volume] in Serum or Plasma
1487
7074
1.47
38.83
2.1
2.1
nmol/l
12.3
14.6
18.33
1293
6171
(3026250) Tacrolimus [Mass/volume] in Blood
189
435
2.99
38.60
30.3
34.7
ug/l
6.9
7.3
0.87
160
395
(3036782) Glucose [Moles/volume] in Pleural fluid
325
988
2.27
38.34
1.3
1.3
mmol/l
6.3
6.7
1.71
302
905
(3002179) Metamyelocytes/100 leukocytes in Blood
1921
9603
1.40
38.33
4.3
3.6
%
0.6
0.6
0.10
460
1634
(3037756) Immunofixation for Serum or Plasma
694
2763
1.74
38.20
1.6
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
1568
7565
1.45
38.05
1.5
1.5
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
209
514
2.80
38.03
2.2
2.0
e6/l
486.6
501.0
0.07
167
439
(3000494) Fungus identified in Specimen by Culture
2908
15547
1.32
37.71
1.5
1.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
1425
6763
1.47
37.63
7.7
9.1
mmol/l
24.2
24.5
2.22
1321
6137
(3025159) Blasts/100 leukocytes in Blood
1908
9576
1.40
37.15
4.4
3.8
%
0.1
0.2
0.26
496
1790
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
318
982
2.24
36.19
1.3
1.3
u/l
471.0
411.8
0.18
302
913
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
1045
4689
1.55
35.97
2.9
1.5
g/l
1.2
0.5
6.09
882
3953
(3012441) Differential panel - Pleural fluid
344
1104
2.15
35.66
1.4
1.5
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
197
488
2.78
35.41
2.2
2.0
e9/l
0.2
0.2
0.69
167
433
(40760892) CBC W Ordered Manual Differential panel - Blood
4655
26599
1.25
35.30
5.1
4.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
2463
12977
1.33
35.20
4.2
3.7
kpa
5.8
5.9
2.93
2395
12594
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
1009
4517
1.55
35.09
3.8
1.6
mg/l
46.6
37.8
1.32
835
3638
(3034860) Kappa light chains.free [Mass/volume] in Serum
1011
4533
1.55
34.92
3.8
1.6
mg/l
116.6
47.0
0.69
837
3657
(3002032) Base excess in Venous blood by calculation
2453
12947
1.33
34.60
4.2
3.8
mmol/l
1.7
2.0
2.53
2035
10617
(3023199) Leukocytes [#/volume] in Pleural fluid
387
1324
2.02
33.99
1.4
1.5
e6/l
2182.8
3468.3
0.80
263
973
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
979
4386
1.55
33.93
3.7
1.6
ratio
5.9
2.1
1.16
78
342
(3028308) Erythrocytes [#/volume] in Pleural fluid
357
1186
2.08
33.92
1.4
1.5
e6/l
71988.4
58396.7
0.31
209
717
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
650
2629
1.71
33.86
1.6
1.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
1292
6140
1.47
33.83
4.1
4.1
mmol/l
24.1
24.2
0.76
1163
5419
(3012544) pH of Venous blood
2537
13518
1.32
33.43
4.2
3.8
ph
7.4
7.4
0.07
11
59
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
626
2516
1.72
33.36
1.7
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
441
1594
1.91
33.15
4.2
2.9
%
1.5
1.3
0.68
352
1194
(3052851) Hemolysis interference index of Serum or Plasma
888
3926
1.57
32.61
3.4
3.3
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
168
402
2.88
32.18
4.7
1.2
u/ml
57.2
302.6
3.60
43
86
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
494
1872
1.83
32.12
1.7
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
1100
5114
1.50
32.11
2.0
1.9
ug/l
2.5
2.1
0.49
947
4441
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
255
756
2.33
31.94
1.3
1.3
u/l
18.4
12.5
1.07
237
682
(21494755) Public health laboratory ask at order entry panel
691
7499
0.62
31.89
1.4
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1190
5637
1.47
31.66
2.7
1.4
g/l
7.3
7.5
2.12
889
4125
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1186
5631
1.47
31.18
2.7
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1183
5620
1.47
31.01
2.7
1.4
g/l
3.8
3.9
0.52
858
3972
(3003694) ABO and Rh group [Type] in Blood
5196
30390
1.22
31.00
1.3
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
16045
103445
1.18
30.99
4.1
4.0
pmol/l
15.1
14.9
6.63
14215
92746
(3045788) Cell count panel - Pleural fluid
310
1011
2.12
30.94
1.4
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
4923
28656
1.22
30.76
1.7
1.7
mg/l
1.5
1.2
4.42
3800
22052
(3006245) CD3-CD19+ cells/100 cells in Blood
117
230
3.50
30.69
1.7
1.9
%
10.6
9.5
0.34
110
212
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
118
234
3.47
30.56
1.7
1.8
%
28.5
25.9
0.86
112
219
(3010503) CD19 cells [#/volume] in Blood
178
454
2.70
30.39
2.3
2.2
e9/l
0.3
0.2
0.65
167
435
(40768797) Stomach Pathology biopsy report
3417
19141
1.26
30.31
1.2
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1118
5276
1.47
30.30
2.7
1.5
g/l
3.0
3.1
0.21
874
4061
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
19738
129736
1.22
30.28
6.6
6.4
mmol/mol
40.2
40.5
4.52
17836
118972
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1117
5272
1.47
30.26
2.6
1.4
g/l
10.1
10.3
0.66
933
4361
(3000060) B lymphocytes [#/volume] in Blood
90
147
4.21
30.23
1.6
1.9
e6/l
1175.3
136.4
0.77
55
90
(3005719) IgG [Mass/volume] in Serum or Plasma
1696
8634
1.37
30.12
3.3
2.3
g/l
10.4
10.8
2.05
1548
7829
(3017143) Hepatitis C virus Ab [Presence] in Serum
1912
9939
1.35
29.69
1.7
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
955
4399
1.51
29.14
2.6
1.5
g/l
37.4
37.5
0.22
805
3695
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
245
746
2.26
28.93
1.7
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
805
3583
1.56
28.72
1.7
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
753
3302
1.58
28.65
3.8
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
20900
138356
1.24
28.58
5.6
5.5
mmol/l
2.6
2.7
50.35
18754
126606
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
664
2829
1.63
28.45
1.3
1.3
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
906
4149
1.52
28.41
2.7
1.5
g/l
0.0
0.0
0.43
823
3753
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
664
2830
1.63
28.41
1.3
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
2000
10537
1.33
28.31
4.8
4.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
7569
46147
1.18
28.06
2.2
2.1
u/l
206.3
218.8
0.42
7024
42902
(3024354) Oxygen [Partial pressure] in Venous blood
2047
10840
1.32
27.95
3.5
3.1
kpa
4.7
4.5
2.51
1987
10486
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
838
3801
1.53
27.48
2.8
1.5
g/l
0.0
0.0
0.00
767
3468
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
849
3864
1.52
27.41
2.8
1.5
g/l
0.0
0.0
0.50
769
3480
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
32
16
13.73
27.40
1.2
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1993
10601
1.31
26.30
1.6
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
930
4364
1.48
25.93
3.3
2.6
g/l
0.3
0.3
0.59
388
1498
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
823
3769
1.51
25.82
1.3
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
2437
13353
1.28
25.65
2.9
3.0
ng/l
242.4
222.3
1.18
2234
12249
(3011397) Hemoglobin [Presence] in Urine by Test strip
5534
33067
1.19
25.44
4.2
3.8
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
242
776
2.15
25.30
1.5
1.4
u/l
14.4
13.4
1.07
231
744
(3019225) pH of Specimen
2577
14242
1.27
25.27
4.7
3.7
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
99
201
3.39
24.86
1.7
2.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
1225
6097
1.40
24.85
1.4
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
186
537
2.39
24.83
1.3
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
423
1659
1.76
24.66
1.5
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
91
176
3.55
24.53
1.1
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
6102
36864
1.18
24.50
4.9
4.2
estimate
0.0
0.0
0.08
2031
11217
(3028026) IgM [Mass/volume] in Serum or Plasma
1348
6839
1.37
24.36
2.2
1.5
g/l
1.5
1.2
2.69
1196
6171
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
1038
5053
1.43
23.89
1.9
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
1114
5495
1.41
23.80
2.1
1.8
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
313
1130
1.91
23.76
2.6
2.0
u/ml
836.0
826.3
0.00
308
1110
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
146
383
2.62
23.75
2.7
2.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
147
388
2.61
23.63
3.9
3.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
391
1520
1.78
23.51
1.6
1.5
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
26
0
+∞
23.28
1.0
0.0
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
675
3041
1.54
22.87
2.3
2.4
g/l
3.6
3.6
0.07
643
2885
(3016228) CD19 cells/100 cells in Blood
113
264
2.94
22.72
1.7
2.0
%
10.4
8.8
0.41
106
254
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
495
2081
1.64
22.44
1.5
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
1326
6799
1.36
22.40
8.2
9.9
—
—
—
0
0
(4281824)
216
696
2.14
22.38
1.2
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1668
8853
1.31
22.27
3.8
3.5
kpa
5.1
5.2
3.97
1534
8114
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1596
8420
1.32
22.24
3.7
3.4
mmol/l
1.7
1.9
1.31
1173
6230
(40761535) Cells panel - Urine sediment
2242
12365
1.27
22.23
4.1
3.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
324
1210
1.85
22.22
1.6
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
1536
8095
1.32
21.56
2.5
2.5
—
—
—
0
0
(3009343) pH of Capillary blood
1639
8729
1.31
21.32
3.8
3.5
ph
7.4
7.4
0.90
254
1061
(46235355) HIV 1 and 2 tests - Meaningful Use set
2226
12347
1.26
20.99
1.6
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
324
1242
1.80
20.48
1.1
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
106
254
2.87
20.45
1.6
2.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1958
10745
1.27
20.17
2.2
1.8
nmol/l
376.1
367.4
0.97
1779
9701
(40767503) Oxygen content in Capillary blood by calculation
622
2832
1.52
20.13
2.7
2.5
%
15.9
16.4
2.32
349
1481
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
20348
135276
1.18
19.70
5.0
4.9
mmol/l
4.5
4.6
40.64
18268
124298
(21494434) Karyotype in Bone marrow
264
970
1.88
19.12
1.1
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
304
1177
1.78
18.64
1.2
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
405
1709
1.64
18.19
2.7
2.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
209
724
1.99
18.00
1.3
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
20154
134126
1.17
17.68
4.9
4.8
mmol/l
1.5
1.5
1.76
17968
122432
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
2457
14050
1.22
17.38
2.4
2.4
ug/l
6.1
7.6
4.23
2076
12157
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
1265
6691
1.31
17.28
2.9
2.8
%
0.7
0.7
0.14
1214
6396
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
424
1839
1.59
17.07
1.6
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
54
94
3.94
16.91
1.2
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
19503
129591
1.15
16.77
4.4
4.3
mmol/l
1.2
1.3
20.74
17211
117245
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
1282
6835
1.30
16.52
2.8
2.8
%
1.1
1.2
3.93
1275
6803
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
418
1832
1.57
16.13
1.5
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
608
2886
1.46
16.11
4.1
3.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
254
979
1.79
15.89
1.6
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
254
979
1.79
15.89
1.6
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
254
979
1.79
15.89
1.6
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
374
1604
1.61
15.81
1.4
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
8146
51463
1.13
15.77
4.8
4.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
1948
10987
1.23
15.69
2.9
2.4
ml/min/173m2
57.7
62.4
6.85
874
4298
(3035880) pH of Pleural fluid
178
613
2.00
15.66
1.3
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
327
1360
1.66
15.62
3.6
3.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
6418
39981
1.14
15.50
3.4
2.6
u/l
35.0
34.5
0.18
6001
37485
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
379
1645
1.59
15.27
1.6
1.5
u/ml
113.0
119.6
0.62
92
365
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
125
381
2.26
14.99
1.4
1.4
%
66.4
63.6
0.39
105
304
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
376
1645
1.58
14.67
6.4
6.2
mg/l
12.3
12.0
0.59
351
1493
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
176
621
1.95
14.50
1.6
1.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
609
2951
1.43
14.50
2.1
2.4
%
206.4
191.7
3.50
570
2772
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
410
1836
1.54
14.45
1.5
1.4
u/ml
20.1
15.1
0.40
11
34
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
175
618
1.95
14.39
1.6
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
1688
9465
1.24
14.34
4.2
4.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
724
3624
1.38
14.29
1.2
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
261
1048
1.72
14.25
1.7
1.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
607
2950
1.42
14.23
3.0
2.9
kpa
8.0
7.9
0.80
576
2736
(3051651) Icteric interference index of Serum or Plasma
178
636
1.93
14.16
3.7
4.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
313
1323
1.63
14.09
2.2
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
730
3668
1.38
14.09
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
728
3657
1.38
14.07
1.2
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
289
1198
1.66
14.03
4.6
2.9
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
648
3197
1.40
13.95
2.0
2.1
%
89.2
90.4
0.69
612
2950
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
197
735
1.84
13.77
1.5
1.3
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
454
2101
1.49
13.74
2.0
1.9
mmol/l
1.6
1.7
1.65
444
2055
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
560
2711
1.43
13.44
1.7
1.6
—
—
—
0
0
(3036489) Thrombin time
830
4288
1.34
13.42
1.8
1.9
s
21.9
21.8
0.15
749
3751
(3010421) pH of Blood
682
3417
1.38
13.41
4.3
4.0
ph
7.4
7.4
1.16
584
2859
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
273
1131
1.66
13.32
1.7
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
532
2559
1.43
13.23
2.9
2.8
—
—
—
0
0
(44806118)
286
1205
1.63
13.08
1.6
1.5
—
—
—
0
0
(44790047)
286
1206
1.63
13.04
1.6
1.5
—
—
—
0
0
(44790048)
286
1206
1.63
13.04
1.6
1.5
—
—
—
0
0
(44790049)
286
1206
1.63
13.04
1.6
1.5
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
107
326
2.26
12.92
1.4
1.4
%
3.3
2.6
0.35
88
268
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1532
12732
0.81
12.84
1.6
1.7
%
1.5
1.5
0.25
1256
10841
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
10653
68845
1.11
12.84
2.4
2.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
3237
19450
1.16
12.84
8.7
7.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
139
472
2.02
12.81
1.7
1.2
—
—
—
0
0
(3020891) Body temperature
1072
5775
1.29
12.80
4.9
4.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
5471
34087
1.13
12.73
4.2
3.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
361
1622
1.53
12.60
1.3
1.2
u/ml
309.5
290.9
0.52
214
1047
(3027315) Oxygen [Partial pressure] in Blood
598
2964
1.39
12.58
4.4
4.1
kpa
8.5
8.4
0.50
589
2882
(3012501) Base excess in Blood by calculation
593
2938
1.39
12.50
4.4
4.1
mmol/l
2.6
2.6
0.04
414
2011
(3013290) Carbon dioxide [Partial pressure] in Blood
593
2940
1.39
12.46
4.4
4.1
kpa
5.0
5.0
1.59
584
2859
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
228
917
1.71
12.44
1.6
1.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
1577
8913
1.23
12.43
3.7
3.3
g/l
126.3
130.1
9.99
1538
8697
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
64
156
2.82
12.17
1.4
1.4
%
11.6
9.2
0.28
34
73
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
84
236
2.45
12.15
2.3
1.4
u/l
18.8
36.0
1.14
77
210
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
1013
5456
1.28
12.13
4.1
3.8
mmol/l
24.8
24.9
0.71
916
4974
(3000570) Elastase.pancreatic [Mass/mass] in Stool
758
3925
1.33
12.10
1.4
1.4
ug/g
264.8
281.9
1.59
467
2301
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
376
1720
1.51
12.10
1.3
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
267
1130
1.63
12.04
2.9
2.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
1159
6361
1.26
11.91
3.9
3.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
502
2438
1.42
11.89
4.2
3.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
316
1398
1.56
11.85
3.4
3.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
149
536
1.91
11.72
1.5
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
149
536
1.91
11.72
1.5
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
256
1084
1.63
11.55
4.1
2.8
%
59.6
61.1
0.43
167
701
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
44
88
3.43
11.51
1.4
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
638
3248
1.36
11.42
2.4
2.1
g/l
127.1
130.5
2.54
447
2349
(3035637) Corticotropin [Mass/volume] in Plasma
249
1056
1.62
11.18
1.3
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
115
384
2.06
11.15
1.5
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
943
5093
1.28
11.08
2.2
2.3
ug/l
419.0
620.4
1.82
886
4783
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
147
540
1.87
10.89
1.7
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
147
540
1.87
10.89
1.7
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
147
540
1.87
10.89
1.7
1.3
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
405
1924
1.45
10.85
1.5
1.4
pmol/l
195.8
82.1
2.40
394
1882
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
18
7
17.64
10.82
1.1
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
147
542
1.86
10.78
1.7
1.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
460
2241
1.42
10.76
1.4
1.2
u/l
44.2
25.2
2.21
392
1924
(3015235) Bicarbonate [Moles/volume] in Capillary blood
690
3592
1.33
10.67
3.1
3.1
mmol/l
24.4
24.9
2.84
617
3162
(3048929) Epstein Barr virus Ab [Presence] in Serum
469
2305
1.40
10.45
1.3
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
1275
7180
1.23
10.43
3.4
2.6
e6/l
0.3
0.3
0.17
1243
6990
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
81
241
2.31
10.42
1.1
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
3679
22616
1.14
10.37
1.6
1.3
g/l
2.6
2.6
0.29
2032
12760
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
12498
81905
1.09
10.27
3.2
3.0
u/l
53.4
48.5
5.74
11278
74729
(3024316) Viscosity of Plasma
20
22
6.24
10.25
1.4
1.4
mpas
1.9
1.4
1.19
13
12
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
5139
32257
1.12
10.20
1.8
1.7
pmol/l
22827340.5
33025785.5
0.74
4061
26192
(3024891) Influenza virus A+B Ag [Presence] in Specimen
555
2823
1.36
10.05
1.2
1.2
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
252
1105
1.57
9.92
1.9
1.7
g/24h
0.4
1.2
2.43
11
60
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
84
260
2.22
9.89
1.4
1.3
ug/l
97.9
37.9
0.63
42
122
(3008152) Bicarbonate [Moles/volume] in Arterial blood
1550
8952
1.20
9.82
6.5
7.0
mmol/l
24.4
24.6
2.09
1449
8336
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
113
397
1.96
9.61
1.9
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
569
2927
1.34
9.59
2.7
3.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
96
318
2.07
9.58
1.4
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
113
398
1.95
9.54
1.9
1.3
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
923
5068
1.26
9.52
3.9
4.1
mmol/l
1.4
1.4
0.33
911
4968
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
114
404
1.94
9.47
1.9
1.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
1192
6740
1.22
9.40
4.7
3.9
%
48.8
47.5
1.06
1181
6663
(3027456) Digoxin [Moles/volume] in Serum or Plasma
636
3339
1.31
9.32
3.2
3.1
nmol/l
0.8
0.8
0.86
497
2601
(3043409) Potassium [Moles/volume] in Arterial blood
813
4417
1.27
9.17
4.1
4.4
mmol/l
3.9
3.9
0.07
773
4156
(3009508) Creatinine [Moles/volume] in Urine
7470
47999
1.10
9.15
3.3
3.2
mmol/l
6.9
7.3
11.91
6082
40045
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
84
271
2.13
8.99
3.0
2.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
504
2578
1.35
8.86
1.3
1.3
mmol/l
59.8
63.6
1.37
409
2051
(3000919) Neutrophils/100 leukocytes in Pleural fluid
90
303
2.04
8.65
1.4
1.4
%
18.0
22.1
0.71
81
268
(3023419) Bacteria identified in Sputum by Culture
368
1801
1.41
8.50
2.6
2.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
401
1992
1.39
8.49
1.4
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
342
1656
1.42
8.39
1.5
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
342
1656
1.42
8.39
1.5
1.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
269
1244
1.49
8.38
1.3
1.4
mosm/kgh2o
278.2
276.4
0.55
204
940
(3012516) Albumin [Mass/volume] in Urine
7331
47212
1.09
8.38
3.4
3.2
mg/l
355.7
324.2
0.25
4536
29425
(3027273) Bicarbonate [Moles/volume] in Venous blood
1262
7260
1.20
8.37
4.2
3.3
mmol/l
25.1
25.4
2.46
1229
7044
(3025468) Yersinia sp identified in Specimen by Organism specific culture
338
1635
1.42
8.34
1.4
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
351
1711
1.41
8.30
1.4
1.3
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
94
327
1.97
8.29
1.3
1.4
mmol/l
3.6
3.3
0.33
89
294
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
55
154
2.45
8.16
5.4
4.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
337
1637
1.42
8.14
1.4
1.3
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
30
59
3.49
8.13
1.7
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
2387
14488
1.14
8.09
2.3
2.1
ug/g
133.3
138.9
0.36
1866
11170
(3005988) Vibrio sp identified in Specimen by Organism specific culture
337
1642
1.41
8.01
1.4
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
283
1336
1.46
7.98
1.3
1.2
u/l
60.4
58.0
0.25
188
858
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
50
137
2.51
7.77
1.9
2.5
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
329
1608
1.41
7.70
1.1
1.1
g/l
1.5
1.5
0.14
299
1430
(3025941) Bacteria identified in Stool by Culture
1172
6753
1.20
7.67
1.3
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
480
4290
0.76
7.60
1.6
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
7693
49837
1.08
7.45
4.2
4.0
mg/mmol
10.3
8.4
2.34
4655
31107
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
153
640
1.64
7.43
1.9
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
125
496
1.73
7.37
1.2
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
1017
8323
0.83
7.31
1.8
1.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
181
793
1.57
7.29
2.2
2.2
—
—
—
0
0
(3000012) Reticulocyte production index
173
752
1.58
7.21
1.5
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
176
770
1.57
7.14
1.1
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
52
153
2.33
7.00
1.6
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
215
993
1.49
6.84
1.2
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
716
3975
1.24
6.82
1.6
1.6
g/l
1.2
1.2
0.33
687
3757
(3014891) Appearance of Pleural fluid
57
177
2.21
6.80
1.5
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
533
2858
1.28
6.80
1.4
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
84
303
1.90
6.76
1.6
1.6
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
53
161
2.26
6.66
7.2
5.1
ug/min
43.6
47.1
0.17
48
124
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
177
789
1.54
6.66
1.7
1.5
u/l
7.1
6.0
0.33
89
351
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
89
330
1.85
6.61
1.5
1.9
u/ml
3889.2
37804.2
0.72
13
54
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
315
2916
0.74
6.47
1.5
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
159
697
1.57
6.45
3.7
4.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
636
5363
0.81
6.25
1.5
1.5
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
12
13
6.33
6.22
1.1
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
183
843
1.49
5.96
1.3
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
168
762
1.52
5.90
1.4
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
112
462
1.67
5.84
1.6
1.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
209
2030
0.70
5.83
1.1
1.1
iu/ml
59.6
6195.3
0.56
45
393
(3009445) Proteinase 3 Ab [Units/volume] in Serum
1073
6295
1.18
5.79
1.6
1.5
u/ml
15.0
16.6
0.16
33
148
(3000764) Benzodiazepines [Presence] in Urine
156
1596
0.67
5.78
1.4
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
143
1488
0.66
5.76
1.5
1.9
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
48
150
2.20
5.71
1.2
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
74
272
1.87
5.70
1.3
1.2
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
53
173
2.10
5.67
3.6
2.5
mg/l
21.8
63.3
—
5
28
(3028300) Cannabinoids [Presence] in Urine
158
1605
0.67
5.65
1.4
1.8
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
179
831
1.48
5.64
1.3
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
158
1602
0.67
5.60
1.4
1.7
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
43
130
2.27
5.53
1.5
1.3
%
13.9
26.9
2.22
33
96
(3035285) Chloride [Moles/volume] in Venous blood
370
1948
1.31
5.51
2.6
2.3
mmol/l
105.9
105.8
0.23
365
1935
(3041354) Potassium [Moles/volume] in Venous blood
370
1948
1.31
5.51
2.6
2.3
mmol/l
4.1
4.1
0.06
365
1936
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
362
1902
1.31
5.48
2.1
2.1
mg/l
29.5
26.3
0.40
103
499
(3020191) Ethanol [Moles/volume] in Serum or Plasma
89
1017
0.60
5.46
1.1
1.4
promille
0.9
1.3
3.25
71
769
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
6
0
+∞
5.37
1.0
0.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
43
132
2.24
5.35
3.3
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
155
1562
0.68
5.35
1.4
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
633
5250
0.82
5.34
1.7
1.6
—
—
—
0
0
(3036603) Volume of Urine
174
814
1.47
5.31
1.9
1.4
ml
1842.0
1950.5
0.35
43
198
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
57
197
1.99
5.28
14.6
11.4
mmol/l
5.9
5.1
0.89
57
197
(3033705) Calcium.ionized [Moles/volume] in Venous blood
364
1925
1.30
5.27
2.6
2.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
891
5192
1.18
5.25
1.3
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
5981
38797
1.08
5.25
1.7
1.7
mmol/l
1.3
1.3
5.83
4886
31990
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
3004
18936
1.10
5.23
5.0
5.0
%
33.7
32.8
3.86
1934
12650
(1001926) Buprenorphine [Presence] in Urine by Screen method
118
1245
0.65
5.14
1.5
1.9
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
36
104
2.38
5.14
1.1
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
21
45
3.20
5.10
1.0
1.0
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
26
64
2.79
5.05
1.0
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
145
663
1.50
4.98
1.2
1.1
iu/ml
3.1
4.1
—
8
47
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
161
753
1.47
4.95
1.4
1.2
u/l
26.5
22.6
0.48
136
630
(46236302) HLA-C [Type] by High resolution typing
11
14
5.39
4.95
1.0
1.1
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
11
14
5.39
4.95
1.0
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
119
524
1.56
4.85
1.2
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
569
4720
0.82
4.85
1.6
1.6
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
79
314
1.73
4.79
2.0
2.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
75
294
1.75
4.77
1.2
1.2
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
29
79
2.52
4.69
2.1
4.4
mg/l
1.0
1.5
1.31
22
71
(3004451) EKG impression Narrative
150
700
1.47
4.69
1.3
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
697
4019
1.19
4.68
1.4
1.5
iu/ml
8.9
16.3
1.73
14
105
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
135
617
1.50
4.67
1.3
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
135
617
1.50
4.67
1.3
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
5939
42838
0.93
4.64
3.3
3.2
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
24
60
2.74
4.56
5.5
4.8
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
163
778
1.44
4.55
1.4
1.2
u/l
100.3
86.9
0.74
139
668
(3013005) Retinol [Moles/volume] in Serum or Plasma
81
331
1.68
4.48
1.5
1.5
umol/l
2.2
2.0
0.80
75
307
(3012565) Volume of 24 hour Urine
135
623
1.49
4.48
2.0
1.9
ml
1689.8
1921.3
1.75
117
538
(3028707) Methadone [Presence] in Urine by Screen method
68
785
0.59
4.43
1.8
2.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
1461
8943
1.13
4.42
3.0
2.9
e9/l
4.2
4.0
0.99
1029
6478
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
14
25
3.84
4.39
10.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
53
192
1.89
4.36
2.1
2.2
—
—
—
0
0
(3013862) HLA-DP [Type]
11
16
4.72
4.34
1.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
26
70
2.55
4.32
5.9
1.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
27
75
2.47
4.23
1.3
1.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
829
4897
1.17
4.22
1.6
1.6
titre
190.0
265.9
0.42
32
245
(3028433) Virus identified in Specimen by Culture
91
392
1.59
4.14
1.3
1.1
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
10
14
4.90
4.10
1.0
1.1
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
10
14
4.90
4.10
1.0
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
25
68
2.52
4.09
2.8
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
1454
8943
1.12
4.08
2.5
2.4
au/ml
30.6
30.5
0.01
59
371
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
64
252
1.74
4.07
1.3
1.4
%
22.2
25.7
0.48
55
207
(3036525) Urea [Moles/time] in 24 hour Urine
28
81
2.37
4.05
3.4
2.7
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
113
1137
0.68
3.99
3.4
3.2
%
13.3
13.3
0.36
113
1120
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
1192
7268
1.13
3.88
3.0
3.0
pmol/l
4.4
4.4
0.62
1010
6340
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
160
786
1.40
3.88
1.1
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
307
1663
1.27
3.82
1.1
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
154
754
1.40
3.81
2.0
1.8
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
301
1627
1.27
3.81
5.4
12.6
mmol/l
7.1
7.6
1.47
250
1326
(3023183) Ammonium ion [Moles/volume] in Plasma
475
2714
1.20
3.62
2.8
2.6
umol/l
33.5
33.2
0.07
390
2305
(3024471) HLA-A [Type]
79
341
1.59
3.61
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
78
336
1.59
3.60
1.1
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
111
518
1.47
3.58
2.8
2.5
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
25
73
2.35
3.57
2.1
2.2
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
51
198
1.77
3.46
1.1
1.1
pmol/l
4.6
3.2
—
5
21
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
35
120
2.00
3.43
2.1
1.2
ng/l
143.9
103.9
—
8
36
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
15
34
3.03
3.40
1.9
1.2
nmol/l
295.8
546.8
1.29
15
34
(40763480) Human metapneumovirus Ag [Presence] in Specimen
15
34
3.03
3.40
1.4
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
63
262
1.65
3.36
1.7
1.7
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
77
337
1.57
3.35
2.0
2.2
e6/l
11017.2
14906.7
0.23
45
171
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
7
6
8.00
3.34
1.0
1.0
—
—
—
0
0
(4198724)
15
258
0.40
3.33
1.1
2.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
409
3364
0.83
3.32
1.5
1.7
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
33
113
2.00
3.26
1.1
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
51
202
1.73
3.26
1.8
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
1307
8103
1.11
3.25
1.3
1.3
au/ml
52.6
52.1
0.02
54
336
(1761482) Bacteria [#/volume] in Urine by Culture
679
4040
1.16
3.24
5.3
4.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
165
843
1.34
3.22
3.2
3.1
—
—
—
0
0
(4212803)
33
114
1.99
3.19
1.1
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
84
380
1.52
3.18
5.8
5.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
919
5591
1.13
3.17
1.9
1.9
u/l
39.4
39.0
0.20
778
4849
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
350
2903
0.82
3.13
1.7
1.5
nmol/l
0.9
0.8
0.50
298
2382
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
858
6623
0.88
3.04
1.2
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
76
341
1.53
3.01
1.2
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
209
1823
0.78
3.00
1.9
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
110
1050
0.72
2.99
2.0
2.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
16279
109805
1.05
2.98
24.9
17.8
g/l
331.2
332.0
24.63
16145
108874
(3008898) HLA-B27 [Presence]
419
3400
0.84
2.96
1.0
1.1
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
6
5
8.23
2.96
1.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
176
921
1.31
2.95
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
309
1732
1.23
2.94
1.1
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
52
214
1.67
2.93
1.1
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
486
2845
1.17
2.90
1.3
1.3
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
59
252
1.61
2.89
1.5
1.6
g/l
27.7
48.2
0.41
52
189
(3035320) C reactive protein [Mass/volume] in Body fluid
178
937
1.30
2.87
2.5
2.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
409
2367
1.19
2.81
1.5
1.5
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
67
299
1.54
2.75
1.4
1.6
g/l
14.8
12.6
1.49
53
215
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
39
151
1.77
2.74
4.2
1.4
u/l
39.4
63.8
0.74
19
62
(4010399)
1713
10856
1.09
2.74
1.5
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
117
583
1.38
2.73
1.2
1.2
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
577
3443
1.15
2.71
3.8
3.2
mmol/l
1.6
1.6
0.55
567
3372
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
31
112
1.90
2.69
1.3
1.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
551
3279
1.16
2.69
3.9
3.3
mmol/l
7.5
7.7
1.13
540
3215
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
964
5951
1.12
2.65
4.7
4.7
%
1.5
1.6
2.66
905
5606
(40758047) Lysozyme [Mass/volume] in Pleural fluid
29
103
1.93
2.65
1.2
1.1
mg/l
7.4
9.2
0.57
29
92
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
31
113
1.88
2.63
1.3
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
31
113
1.88
2.63
1.3
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
58
254
1.57
2.60
1.1
1.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
9
16
3.86
2.58
1.4
1.6
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
127
648
1.35
2.58
1.2
1.1
u/l
89.4
84.8
0.24
103
498
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
127
649
1.34
2.56
1.2
1.1
u/l
29.7
22.6
0.75
101
479
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
94
457
1.41
2.55
1.1
1.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
81
383
1.45
2.55
2.1
2.3
e6/l
1950.9
2254.4
0.06
56
269
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
36
140
1.76
2.52
1.2
1.3
u/l
177.3
270.1
0.14
23
91
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
32
120
1.83
2.51
1.3
1.1
u/l
20.7
18.4
0.20
26
70
(3029634) Reagin Ab [Titer] in Serum by VDRL
248
1386
1.23
2.49
2.8
2.0
titre
24.8
5.3
—
6
27
(3044927) Protein electrophoresis panel - Urine
290
1647
1.21
2.49
1.2
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
4117
26979
1.06
2.48
1.3
1.2
u/ml
1.6
1.7
0.23
988
7019
(3007930) Methemoglobin/Hemoglobin.total in Blood
945
5852
1.11
2.48
4.7
4.7
%
0.9
0.9
0.64
888
5506
(3016038) Potassium [Moles/volume] in Urine
183
989
1.27
2.47
1.1
1.1
mmol/l
36.0
33.7
0.62
152
817
(3052592) Norovirus Ag [Presence] in Stool
58
258
1.54
2.45
1.3
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
128
661
1.33
2.42
1.1
1.1
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
8
14
3.92
2.38
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
366
2134
1.18
2.37
1.2
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
332
1920
1.19
2.36
1.3
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
497
2970
1.15
2.34
1.5
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
44
471
0.64
2.27
1.2
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
41
171
1.64
2.27
1.1
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
41
171
1.64
2.27
1.2
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
140
740
1.30
2.27
2.0
2.2
ug/min
95.0
128.1
0.32
27
174
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
582
3525
1.14
2.26
2.0
2.0
mg/l
11.9
11.3
1.02
535
3248
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
8
15
3.66
2.24
1.5
1.3
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
25
90
1.91
2.24
1.9
2.5
%
59.8
60.2
0.01
19
55
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
137
724
1.30
2.23
1.3
1.3
nmol/l
0.3
0.2
0.27
104
531
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
31
120
1.77
2.23
1.2
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
491
2944
1.15
2.23
1.3
1.3
titre
178.6
129.1
0.31
14
64
(3043410) Blood group antigens tested for on Red Blood Cells
64
299
1.47
2.19
2.3
1.6
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
38
157
1.66
2.19
2.2
2.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
278
2264
0.84
2.16
1.9
1.7
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
69
329
1.44
2.14
1.7
1.6
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
12
32
2.57
2.12
1.5
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
3100
22290
0.95
2.10
1.3
1.3
u/ml
13.6
14.9
0.37
1026
8166
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
23
283
0.56
2.10
7.1
7.5
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
106
546
1.33
2.09
2.1
4.8
mg/l
2159.0
520.9
0.37
66
375
(3002619) Bacteria identified in Specimen by Culture
58
269
1.48
2.08
1.3
1.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
116
1031
0.77
2.06
1.1
1.0
u/ml
2.1
2.9
0.41
46
398
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
236
1345
1.20
2.02
1.1
1.1
—
—
—
0
0
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
15
46
2.24
2.01
1.8
1.4
mg/l
1.7
2.0
—
8
26
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
15
46
2.24
2.01
1.8
1.4
mg/l
0.4
0.6
—
9
30
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
15
46
2.24
2.01
1.8
1.4
mg/l
3.2
0.6
—
10
30
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
15
46
2.24
2.01
1.8
1.4
mg/l
3.1
1.3
—
10
31
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
3294
23618
0.95
2.01
1.3
1.3
iu/ml
33.6
40.4
1.79
1015
7417
(3019150) Specific gravity of Urine by Refractometry
4651
30740
1.05
1.99
5.0
4.3
kg/l
1.0
1.0
0.55
653
4701
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
171
945
1.24
1.98
1.1
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
38
162
1.61
1.98
2.2
2.0
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
153
836
1.26
1.96
2.4
2.0
umol/l
14.6
16.4
0.31
11
78
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
125
667
1.29
1.94
2.5
2.4
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
145
1244
0.80
1.94
1.1
1.0
ng/l
37.9
45.2
1.38
93
835
(3008401) Mugwort IgE Ab [Units/volume] in Serum
160
1357
0.81
1.93
1.1
1.1
u/ml
1.0
0.9
0.14
68
513
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
15
47
2.19
1.93
1.1
1.1
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
39
169
1.58
1.91
1.2
1.2
mmol/l
0.7
1.5
0.78
24
96
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
81
407
1.37
1.91
6.8
5.8
%
71.8
70.8
0.13
63
340
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
121
645
1.29
1.90
1.1
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
257
2080
0.85
1.90
1.9
1.8
mu/l
454.5
307.7
0.48
233
1902
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
109
573
1.31
1.90
2.1
1.9
%
100.3
95.8
0.62
104
535
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
145
1240
0.80
1.90
1.1
1.0
ng/l
699.2
719.9
0.22
95
816
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
20
71
1.93
1.89
1.1
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
109
964
0.77
1.89
1.1
1.0
u/ml
3.4
2.7
0.20
43
363
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
278
1620
1.18
1.89
1.1
1.1
au/ml
14.0
13.7
0.02
13
62
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
63
304
1.42
1.87
1.2
1.1
%
84.2
90.3
0.52
26
155
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
191
1584
0.83
1.86
1.1
1.1
u/ml
1.3
1.1
0.19
70
610
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
292
1711
1.17
1.86
1.3
1.2
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
15
48
2.14
1.85
1.8
1.4
mg/l
0.7
1.4
—
10
30
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
145
1233
0.81
1.82
1.1
1.0
ng/l
303.0
334.4
0.84
94
844
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
91
470
1.33
1.81
1.5
1.7
%
165.1
156.4
0.38
82
438
(40762365) Oxygen content in Arterial blood by calculation
42
188
1.53
1.81
2.9
2.6
ml/dl
14.4
15.2
0.89
37
172
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
182
1508
0.83
1.78
1.2
1.2
mmol/l
7.9
7.6
0.50
131
1059
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
315
1865
1.16
1.77
1.3
1.2
nmol/l
3.4
2.0
0.20
298
1788
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
37
162
1.57
1.76
1.8
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
316
1874
1.16
1.75
1.3
1.2
nmol/l
0.2
0.3
0.44
21
141
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
630
3906
1.11
1.72
1.7
1.6
g/l
0.2
0.2
0.32
598
3692
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
417
3228
0.88
1.71
1.1
1.1
u/ml
9.0
9.8
0.06
33
287
(4062490)
220
1270
1.19
1.70
1.6
1.4
—
—
—
0
0
(4034850)
672
5065
0.91
1.70
13.0
10.3
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
33
142
1.59
1.69
1.3
1.2
ug/l
79.7
121.0
1.27
23
92
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
10
149
0.46
1.69
1.2
1.2
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
7
16
3.00
1.68
2.3
3.2
—
—
—
0
0
(3025315) Body weight
29
121
1.64
1.67
5.0
5.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
35
154
1.56
1.65
1.2
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
26
106
1.68
1.64
1.1
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
163
920
1.22
1.61
1.2
1.3
mmol/l
2.3
2.2
0.22
146
854
(3027974) Hepatitis B virus e Ag [Presence] in Serum
15
51
2.02
1.61
1.4
1.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
219
1271
1.18
1.61
1.6
1.4
g/l
0.4
0.4
0.78
155
893
(3028192) IgG subclass 2 [Mass/volume] in Serum
219
1271
1.18
1.61
1.6
1.4
g/l
2.6
3.0
2.73
155
888
(3027135) IgG subclass 1 [Mass/volume] in Serum
219
1272
1.18
1.60
1.6
1.4
g/l
6.1
6.9
3.24
155
888
(3038071) Oxygen [Partial pressure] in Mixed venous blood
34
352
0.66
1.60
8.6
7.7
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
45
211
1.46
1.60
1.3
1.2
%
94.1
86.0
0.27
12
77
(3025577) Chromium [Mass/volume] in Blood
199
1147
1.19
1.59
2.0
2.1
ug/l
2.4
2.4
0.11
166
953
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
13
42
2.12
1.58
1.7
1.4
%
2.5
2.2
0.16
13
42
(21494227) Amikacin free [Mass/volume] in Serum or Plasma
6
13
3.16
1.58
5.8
3.6
mg/l
4.4
4.6
—
6
7
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
20
77
1.78
1.53
1.6
2.5
%
18.1
14.0
0.21
15
38
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
45
213
1.45
1.53
1.3
1.2
%
80.9
74.8
0.26
12
75
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
63
317
1.36
1.53
1.2
1.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
17
62
1.88
1.53
3.4
3.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
20
230
0.60
1.50
1.6
1.5
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
200
1161
1.18
1.49
2.4
1.8
titre
3253.3
3802.9
—
9
41
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
11
34
2.22
1.48
1.0
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
33
337
0.67
1.47
1.5
1.5
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
203
1182
1.18
1.47
1.9
2.0
ug/l
3.4
3.9
0.64
182
1046
(3010726) Horse dander IgE Ab [Units/volume] in Serum
142
1178
0.83
1.46
1.1
1.1
u/ml
0.8
1.4
0.74
32
260
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
40
187
1.47
1.46
1.1
1.3
ng/l
80.3
123.0
0.71
27
133
(3014148) Varicella zoster virus Ab [Titer] in Serum
191
1107
1.18
1.46
1.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
52
256
1.39
1.45
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
407
2494
1.12
1.44
1.3
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
206
1204
1.17
1.43
1.1
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
13
166
0.54
1.43
1.9
1.9
umol/l
17.9
18.3
0.05
13
166
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
24
100
1.65
1.43
1.4
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
1458
9441
1.06
1.42
1.2
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
172
1397
0.84
1.42
1.1
1.1
u/ml
3.6
2.8
0.33
82
628
(3009214) Lutropin [Units/volume] in Serum or Plasma
307
1851
1.14
1.41
1.3
1.3
u/l
13.3
10.6
2.21
243
1465
(3007919) Fasciola sp Ab [Titer] in Serum
7
19
2.53
1.40
1.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
76
400
1.30
1.40
1.9
1.6
mmol/l
0.5
0.6
0.08
71
380
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
9
27
2.29
1.39
10.0
7.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
61
311
1.35
1.39
1.1
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
61
311
1.35
1.39
1.1
1.1
%
84.7
89.2
0.51
24
154
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
140
793
1.21
1.39
1.7
1.4
u/l
5.6
5.8
0.16
117
666
(3044941) Cell count panel - Synovial fluid
410
2520
1.12
1.38
1.5
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
638
4015
1.09
1.36
1.7
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
378
2316
1.12
1.35
1.4
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
30
306
0.67
1.35
1.6
1.7
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
39
185
1.45
1.35
1.2
1.3
nmol/l
233345.2
318674.2
0.12
27
150
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
62
319
1.33
1.34
1.2
1.2
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
48
237
1.39
1.34
1.2
1.2
mmol/l
1.3
1.5
0.72
27
120
(3039000) Anion gap in Blood
479
2976
1.11
1.34
5.9
6.5
mmol/l
11.3
11.3
0.01
426
2687
(3018572) Chloride [Moles/volume] in Blood
479
2976
1.11
1.34
5.9
6.5
mmol/l
105.0
104.8
0.43
426
2687
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
13
162
0.55
1.33
1.1
1.0
—
—
—
0
0
(3016750) Collection duration of Urine
156
897
1.19
1.33
2.6
2.1
min
498.3
500.1
0.09
114
676
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
38
180
1.45
1.32
1.0
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
62
320
1.33
1.32
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
48
448
0.73
1.32
1.5
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
208
1228
1.16
1.30
1.5
1.6
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
99
839
0.81
1.30
1.1
1.0
u/ml
0.4
0.4
0.00
29
198
(3030313) Adrenal Ab [Titer] in Serum
16
61
1.80
1.29
1.0
1.1
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
23
98
1.61
1.28
1.0
1.1
u/l
7.3
11.5
0.72
23
98
(3016244) Insulin [Units/volume] in Serum or Plasma
90
492
1.26
1.26
2.5
3.1
mu/l
29.2
24.6
0.35
84
461
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
21
88
1.64
1.25
1.1
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
994
6391
1.07
1.24
2.0
1.9
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
341
2609
0.89
1.23
1.4
1.3
iu/l
34.9
36.3
0.30
300
2257
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
17
192
0.61
1.23
1.1
1.4
mmol/l
9.1
9.4
—
7
107
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
15
57
1.80
1.23
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
1189
7697
1.06
1.21
4.4
3.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
43
213
1.38
1.20
1.2
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
21
89
1.62
1.20
1.0
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
100
837
0.82
1.19
1.2
1.4
pmol/l
82.3
109.2
0.29
35
243
(3013762) Body weight Measured
10
33
2.08
1.18
1.0
1.3
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
25
0.00
1.18
0.0
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
214
1278
1.15
1.18
1.6
1.6
u/ml
25.3
25.6
0.03
37
286
(21491868) Cryoglobulin [Mass/volume] in Serum
80
436
1.26
1.17
1.1
1.2
g/l
0.7
0.4
—
6
27
(3009466) Valproate [Moles/volume] in Serum or Plasma
250
1940
0.88
1.17
4.4
4.7
umol/l
333.7
359.6
1.99
209
1635
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
23
101
1.56
1.15
1.1
1.1
iu/ml
6.7
14.8
—
6
29
(3037522) Nuclear Ab [Titer] in Serum
2704
17897
1.04
1.14
1.3
1.3
titre
462.4
573.2
3.02
575
4026
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
44
405
0.74
1.14
10.2
7.8
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
7
20
2.40
1.14
2.3
2.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
327
2013
1.12
1.13
1.7
1.6
g/l
0.7
0.8
1.73
251
1515
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
36
175
1.41
1.13
1.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
59
311
1.30
1.12
2.2
2.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
202
1207
1.15
1.12
2.1
2.1
u/field
2.5
2.3
0.09
80
440
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
16
178
0.62
1.11
1.0
1.1
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
10
34
2.02
1.11
1.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
43
395
0.75
1.10
1.7
1.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
791
5073
1.07
1.10
1.1
1.1
u/ml
3.6
9.5
0.49
12
74
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
30
142
1.45
1.09
1.1
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
138
804
1.18
1.07
11.0
10.6
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
44
224
1.35
1.07
1.6
1.6
ug/l
122.5
120.4
0.04
36
187
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
15
60
1.71
1.06
1.1
1.1
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
7
22
2.18
1.06
1.0
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
64
345
1.27
1.05
1.1
1.2
pmol/l
302.7
289.6
0.08
45
238
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
9
31
1.99
1.05
1.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
13
50
1.78
1.04
1.5
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
539
3418
1.08
1.03
1.2
1.2
titre
868.3
1113.5
0.51
12
124
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
120
694
1.19
1.03
1.5
1.7
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
93
525
1.22
1.02
1.3
1.3
umol/l
20.5
22.1
0.21
87
487
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
466
2940
1.09
1.01
1.2
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
77
648
0.81
1.01
1.1
1.2
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
48
251
1.31
0.99
1.4
1.3
titre
334.9
200.1
—
7
25
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
13
51
1.75
0.99
1.0
1.1
%
20.7
22.0
0.73
13
44
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
13
51
1.75
0.99
1.0
1.1
%
36.2
36.3
0.03
13
44
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
13
51
1.75
0.99
1.0
1.1
%
8.8
9.1
0.15
13
44
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
7
24
2.00
0.98
1.0
1.2
%
3.0
2.8
—
7
24
(3007566) Smooth muscle Ab [Titer] in Serum
535
3401
1.08
0.98
1.2
1.2
titre
166.7
139.5
0.17
46
286
(3016018) Differential panel - Cerebral spinal fluid
213
1293
1.13
0.97
1.3
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
25
244
0.70
0.96
1.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
112
650
1.18
0.94
1.1
1.2
nmol/l
134.6
137.4
0.21
112
650
(3010370) Gastrin [Moles/volume] in Serum or Plasma
29
141
1.41
0.94
2.1
1.4
pmol/l
40.1
56.2
0.55
24
115
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
77
642
0.82
0.94
1.2
1.3
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
80
450
1.22
0.93
1.4
1.4
pmol/l
15.5
16.1
0.41
66
381
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
41
368
0.76
0.93
1.7
1.4
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
127
746
1.17
0.93
2.0
1.9
u/field
2.0
2.3
0.27
92
500
(3047181) Lactate [Moles/volume] in Blood
661
4245
1.07
0.93
5.2
5.7
mmol/l
1.4
1.3
0.25
580
3767
(4015189)
82
463
1.21
0.93
2.0
2.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
142
842
1.16
0.92
1.5
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
41
367
0.77
0.92
1.7
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
193
1170
1.13
0.92
1.4
1.5
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
19
85
1.53
0.92
1.6
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
41
366
0.77
0.90
1.7
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
41
366
0.77
0.90
1.7
1.4
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
62
526
0.81
0.90
1.1
1.1
u/ml
2.5
8.1
—
6
44
(4024509)
245
1509
1.11
0.90
1.6
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
488
3106
1.08
0.89
1.5
1.4
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
24
114
1.44
0.89
1.1
1.3
%
21.5
23.2
—
8
31
(37021550) Renin [Units/volume] in Plasma --upright
53
287
1.27
0.88
1.2
1.2
mu/l
68.6
65.5
0.05
35
200
(3036670) Protein [Mass/volume] in Synovial fluid
91
523
1.19
0.87
1.2
1.3
g/l
40.0
39.7
0.05
40
278
(3017569) Oxygen content in Arterial blood
116
681
1.17
0.87
1.9
2.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
107
624
1.18
0.87
1.1
1.0
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
106
618
1.18
0.87
1.2
1.5
umol/l
15.4
9.9
0.48
74
438
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
40
209
1.31
0.86
1.1
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
294
1835
1.10
0.85
1.4
1.3
mu/l
32.4
56.9
5.66
252
1633
(3024869) Neuronal Ab [Presence] in Serum
44
234
1.29
0.84
1.1
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
2408
16014
1.03
0.83
1.3
1.4
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
276
1721
1.10
0.82
1.3
1.3
pmol/l
252.1
269.2
0.63
231
1304
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
122
964
0.87
0.82
1.2
1.2
mmol/l
11.7
11.9
0.10
45
284
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
17
0.00
0.81
0.0
1.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
1143
7494
1.05
0.81
1.3
1.3
u/ml
344.2
227.7
0.64
1045
6923
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
1974
13988
0.96
0.81
1.6
1.6
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
11
44
1.71
0.80
6.4
5.7
umol/l
396.5
398.7
0.01
11
44
(3015171) Extractable nuclear Ab [Units/volume] in Serum
823
5352
1.06
0.80
1.2
1.2
u/ml
0.9
0.7
0.27
83
499
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
536
3923
0.94
0.80
1.6
1.7
mg/l
2.9
3.6
0.93
376
2784
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
11
122
0.62
0.80
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
1492
9844
1.04
0.80
1.2
1.2
—
—
—
0
0
(4133840)
35
312
0.77
0.79
1.3
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
112
887
0.87
0.79
1.5
1.7
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
71
583
0.83
0.78
1.1
1.0
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
5
16
2.14
0.75
1.0
1.1
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
81
655
0.85
0.75
1.0
1.1
u/ml
1.6
5.2
—
9
96
(3027923) C peptide [Moles/volume] in Serum or Plasma
103
817
0.86
0.75
1.2
1.4
nmol/l
1.0
1.3
2.47
82
622
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
118
704
1.15
0.75
1.0
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
127
762
1.14
0.75
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
1751
11610
1.04
0.74
1.7
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
37
324
0.78
0.74
1.8
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
83
483
1.18
0.73
1.2
1.2
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
14
62
1.55
0.73
2.0
1.1
pmol/l
49.6
1.5
—
5
12
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
254
1904
0.91
0.72
1.4
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
2496
16658
1.03
0.72
1.4
1.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
208
1290
1.11
0.72
2.5
2.3
ml
724.9
662.8
1.10
139
882
(3006270) Folate [Moles/volume] in Blood
205
1271
1.11
0.72
1.2
1.2
nmol/l
306.6
341.2
1.60
165
1033
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
117
701
1.14
0.71
1.0
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
621
4025
1.06
0.71
1.7
1.6
e6/l
14058.2
13744.8
0.06
431
2923
(3051101) Glucose [Moles/volume] in Cord blood
41
352
0.80
0.71
6.4
6.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
226
1701
0.91
0.71
1.1
1.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
490
3155
1.07
0.70
1.3
1.3
mg/l
609.2
539.0
1.30
461
2982
(3010937) Rubella virus Ab [Presence] in Serum
7
28
1.71
0.70
1.1
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
219
1366
1.10
0.69
1.7
1.5
iu/ml
42.9
27.2
0.46
14
67
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
175
1080
1.11
0.68
1.3
1.3
titre
458.8
405.8
0.13
17
97
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
431
2768
1.07
0.67
1.2
1.2
mmol/l
3.8
3.9
1.10
392
2604
(3006576) Bicarbonate [Moles/volume] in Blood
68
551
0.85
0.67
9.2
6.4
mmol/l
25.2
25.3
0.09
57
497
(3047352) Trisomy 18 risk [Likelihood] in Fetus
36
311
0.79
0.67
1.7
1.4
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
16
75
1.46
0.66
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
134
817
1.13
0.65
1.3
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
42
355
0.81
0.65
1.6
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
591
4274
0.95
0.65
1.5
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
135
824
1.12
0.64
1.3
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
405
2962
0.94
0.64
1.6
1.7
nmol/l
47.8
45.0
1.49
387
2838
(3005033) Fetal Nuchal fold Thickness US
36
309
0.80
0.64
1.7
1.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
72
0.57
0.63
2.0
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
92
548
1.15
0.63
1.1
1.1
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
8
33
1.66
0.63
1.0
1.0
u/l
173.1
554.2
—
8
26
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
13
59
1.51
0.62
1.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
17
82
1.42
0.62
2.1
1.6
—
—
—
0
0
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
0
14
0.00
0.62
0.0
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
8
34
1.61
0.62
2.4
3.8
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
58
472
0.84
0.62
1.0
1.0
u/ml
0.6
0.7
0.01
18
146
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
171
1293
0.91
0.62
1.3
1.3
nmol/l
1.4
1.4
0.21
153
1173
(3019977) pH of Arterial blood
131
802
1.12
0.61
1.9
2.3
ph
7.4
7.4
0.98
58
273
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
115
887
0.89
0.60
1.4
1.3
u/l
39.3
36.9
0.32
97
654
(3016330) Potassium [Moles/time] in 24 hour Urine
35
191
1.26
0.60
1.2
1.2
—
88.8
—
0
8
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
32
174
1.26
0.57
1.1
1.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
5
63
0.54
0.57
1.0
1.3
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
26
228
0.78
0.57
1.3
1.6
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
167
1043
1.10
0.55
1.3
1.3
titre
75.0
60.5
0.32
14
83
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
56
325
1.18
0.55
1.6
1.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
734
4822
1.04
0.55
1.6
1.6
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
443
3209
0.95
0.55
3.9
3.5
mg/l
32.6
25.9
2.65
260
2076
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
101
614
1.13
0.54
1.1
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
35
194
1.24
0.54
1.1
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
92
713
0.88
0.54
3.4
2.3
mmol/l
8.9
9.0
0.05
70
519
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
183
1367
0.92
0.54
1.1
1.1
u/ml
3.3
4.1
0.32
59
509
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
46
376
0.84
0.54
1.0
1.1
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
9
42
1.47
0.54
1.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
6
67
0.61
0.53
5.5
8.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
122
929
0.90
0.53
1.4
1.3
u/ml
2.1
1.2
0.49
68
488
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
20
103
1.33
0.53
1.1
1.3
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
10
45
1.52
0.51
1.6
1.5
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
19
98
1.33
0.50
1.1
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
7
30
1.60
0.50
1.0
1.2
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
7
30
1.60
0.50
1.6
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
56
329
1.17
0.49
1.1
1.1
—
—
—
0
0
(4094501)
580
4155
0.96
0.49
1.1
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
183
1157
1.09
0.49
1.8
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
274
2004
0.94
0.48
1.2
1.3
miu/ml
176.5
205.5
0.65
103
823
(3049242) von Willebrand panel - Platelet poor plasma
7
32
1.50
0.48
1.3
1.5
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
7
32
1.50
0.48
2.1
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
15
75
1.37
0.47
1.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
150
942
1.09
0.47
1.1
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
51
299
1.17
0.47
1.1
1.2
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
10
46
1.49
0.47
1.0
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
63
376
1.15
0.47
1.2
1.3
nmol/l
128.4
142.5
0.30
47
260
(3020650) Glucose [Presence] in Urine
50
293
1.17
0.46
1.4
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
903
5986
1.04
0.46
1.0
1.1
—
—
—
0
0
(4027681)
71
551
0.88
0.45
1.2
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
26
143
1.25
0.45
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
150
945
1.09
0.45
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
150
945
1.09
0.45
1.1
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
588
3870
1.04
0.44
1.6
1.6
iu/ml
14.4
6.8
0.32
146
857
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
131
821
1.09
0.44
1.3
1.4
umol/l
14.2
13.4
0.49
125
771
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
57
448
0.87
0.44
1.8
2.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
57
448
0.87
0.44
1.8
2.4
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
5
21
1.63
0.43
2.6
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
13
120
0.74
0.43
1.5
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
51
302
1.16
0.43
1.1
1.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
172
1093
1.08
0.43
1.1
1.2
titre
380.0
118.9
—
5
37
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
321
2084
1.06
0.42
1.5
1.5
%
62.9
59.1
0.89
186
1325
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
19
101
1.29
0.42
1.8
2.2
mmol/l
1.4
1.0
0.25
12
61
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
11
53
1.42
0.42
1.1
1.2
u/l
1155.4
258.4
0.42
11
44
(43055514) Macroprolactin [Presence] in Serum or Plasma
15
135
0.76
0.42
1.3
1.5
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
8
39
1.41
0.42
1.1
1.4
%
1.3
1.3
—
8
39
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
150
949
1.08
0.42
1.1
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
73
445
1.13
0.41
1.1
1.1
miu/ml
1827.5
1619.7
0.75
73
445
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
76
583
0.89
0.41
1.7
1.5
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
172
1095
1.08
0.41
1.1
1.2
titre
117.1
181.5
0.84
34
201
(3044242) Glucose [Moles/volume] in Arterial blood
109
680
1.10
0.41
1.6
1.8
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
150
950
1.08
0.41
1.1
1.2
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
5
23
1.49
0.41
1.0
1.1
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
13
0.00
0.40
0.0
7.3
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
13
0.00
0.40
0.0
1.0
—
141.1
—
0
13
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
150
951
1.08
0.40
1.1
1.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
73
560
0.89
0.40
1.8
2.0
ug/l
19.6
434.3
1.43
66
527
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
43
342
0.86
0.40
1.6
1.9
mg/l
9.8
9.2
0.24
33
276
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
18
96
1.29
0.40
1.1
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
40
234
1.17
0.40
1.4
1.1
ug/l
3.9
2.5
0.64
20
153
(3034891) Synovial lining cells/100 cells in Synovial fluid
125
787
1.09
0.40
1.4
1.5
%
1.4
4.3
3.61
22
172
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
261
1691
1.06
0.39
1.2
1.2
u/ml
3.6
3.8
0.07
99
590
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
291
2103
0.95
0.38
1.8
1.9
pmol/l
201.4
195.1
0.50
262
1966
(3034092) Cytoplasmic Ig cells/100 cells in Blood
19
163
0.80
0.38
10.3
10.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
20
109
1.26
0.38
1.1
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
9
46
1.34
0.38
1.4
1.2
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
66
507
0.89
0.38
1.2
1.7
nmol/l
1.7
4.3
2.62
60
417
(3029075) Extractable nuclear Ab panel - Serum
60
364
1.13
0.38
1.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
17
91
1.28
0.37
3.3
2.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
57
441
0.89
0.37
1.8
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
54
326
1.14
0.37
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
177
1135
1.07
0.37
1.1
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
103
771
0.92
0.37
1.1
1.1
mg/l
46.8
42.8
0.30
87
654
(3017315) Amylase [Enzymatic activity/volume] in Urine
118
745
1.09
0.36
1.2
1.2
u/l
180.0
335.3
2.31
108
691
(3002523) Influenza virus A Ag [Presence] in Specimen
177
1136
1.07
0.36
1.1
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
591
3914
1.04
0.36
2.6
2.3
ug/min
132.2
107.6
0.57
335
2249
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
6
29
1.42
0.35
1.8
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
21
176
0.82
0.35
1.6
2.7
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
53
321
1.13
0.35
1.0
1.1
umol/24h
0.6
0.7
0.26
23
142
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
51
395
0.88
0.34
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
51
395
0.88
0.34
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
51
395
0.88
0.34
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
51
395
0.88
0.34
1.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
254
1653
1.05
0.34
1.2
1.2
u/ml
3.4
3.9
0.43
114
743
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
83
518
1.10
0.34
2.4
2.2
umol/l
61.1
57.3
0.49
61
401
(3018738) Hemoglobin F/Hemoglobin.total in Blood
6
31
1.33
0.33
1.0
4.9
—
27.8
—
0
16
(3036071) Salmonella sp Ab [Titer] in Serum
54
329
1.13
0.33
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
54
330
1.12
0.32
1.1
1.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
108
800
0.93
0.32
1.8
2.0
nmol/l
13.9
15.6
2.02
103
738
(3020123) Porphyrins [Interpretation] in Serum or Plasma
7
68
0.71
0.31
1.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
93
692
0.92
0.31
1.0
1.1
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
11
57
1.32
0.30
1.6
1.7
u/l
0.8
0.4
—
5
14
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
26
151
1.18
0.30
1.5
1.6
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
54
332
1.12
0.30
1.1
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
809
5408
1.03
0.29
1.1
1.1
titre
106.4
211.6
1.09
11
124
(1002224) Polysomnography panel
616
4347
0.97
0.29
1.1
1.1
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
15
82
1.25
0.29
1.1
1.1
u/l
39.8
54.3
—
10
64
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
15
127
0.81
0.29
1.0
1.1
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
8
42
1.31
0.28
1.0
1.0
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
8
44
1.25
0.27
1.4
1.0
nmol/l
201.5
306.4
—
8
44
(3034988) Calcium [Moles/volume] in Capillary blood
44
269
1.12
0.27
2.0
1.7
mmol/l
1.2
1.2
0.49
44
261
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
214
1400
1.05
0.26
1.3
1.3
—
43.4
—
0
9
(3042951) Complement C1q Ab [Units/volume] in Serum
5
51
0.67
0.26
1.2
1.2
—
17.2
—
0
10
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
52
0.66
0.26
1.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
25
147
1.17
0.26
1.6
1.6
umol/l
53.3
46.7
0.37
25
147
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
56
349
1.10
0.26
1.6
1.6
ng/l
144.8
118.0
0.55
56
349
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
251
1650
1.04
0.25
1.4
1.2
nmol/l
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
9
50
1.23
0.25
1.0
1.2
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
12
65
1.27
0.25
1.2
1.4
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
152
987
1.06
0.25
2.2
2.0
mmol/l
7.3
7.0
0.50
109
671
(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
9
52
1.19
0.25
1.2
1.3
mg/l
1.9
1.9
—
9
44
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
63
396
1.09
0.25
1.4
1.2
%
29.6
23.1
0.23
11
57
(3029396) Erythrocyte agglutination [Presence] in Blood
11
59
1.28
0.25
2.0
2.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
282
2008
0.96
0.24
1.2
1.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
15
124
0.83
0.24
1.3
1.1
—
—
—
0
0
(3019298) Eosinophils/100 leukocytes in Peritoneal fluid
5
25
1.37
0.24
1.4
1.8
%
0.6
0.2
—
5
20
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
103
752
0.94
0.23
1.7
1.5
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
5
26
1.32
0.23
1.0
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
1372
9555
0.98
0.23
3.3
3.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
415
2762
1.03
0.23
1.3
1.4
e6/l
84.8
26.5
0.76
310
2164
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
415
2765
1.03
0.22
1.4
1.4
e6/l
6115.0
1501.7
0.42
330
2286
(3025886) Oxalate [Mass/time] in 24 hour Urine
5
28
1.22
0.22
1.2
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
32
195
1.13
0.22
1.1
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
74
545
0.93
0.22
1.0
1.1
u/l
1.2
1.1
0.93
38
269
(3025504) Homovanillate [Moles/time] in 24 hour Urine
0
7
0.00
0.22
0.0
1.1
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
123
890
0.95
0.22
1.6
1.7
umol/l
66.5
70.7
—
8
51
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
74
472
1.08
0.22
1.3
1.4
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
35
215
1.12
0.21
1.4
1.3
%
51.1
47.5
0.14
15
96
(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay
0
9
0.00
0.21
0.0
1.6
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
52
327
1.09
0.21
1.2
1.1
—
—
—
0
0
(4146454)
269
1909
0.97
0.21
2.7
2.7
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
167
1197
0.96
0.21
1.1
1.2
u/ml
65.6
84.9
—
7
53
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
158
1134
0.95
0.21
1.1
1.2
u/ml
29.2
6.3
—
5
75
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
38
288
0.90
0.21
1.8
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
233
1657
0.96
0.21
1.1
1.1
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
22
131
1.15
0.21
9.6
1.8
mmol/l
6.9
7.2
0.25
15
66
(3006462) Nitrate [Presence] in Urine
109
707
1.06
0.20
4.1
3.3
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
78
571
0.94
0.20
1.3
1.2
%
54.9
54.5
—
9
54
(44806420)
80
514
1.07
0.20
2.3
2.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
138
992
0.95
0.20
2.1
1.7
u/l
1263.1
2302.5
0.56
49
366
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
168
1201
0.96
0.19
1.1
1.2
u/ml
37.3
46.8
—
9
90
(3014051) Protein [Presence] in Urine by Test strip
493
3302
1.02
0.19
2.2
2.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
36
272
0.91
0.19
2.8
2.8
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
238
1577
1.04
0.19
1.4
1.4
e6/l
81579.1
137936.6
0.82
159
1077
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
10
84
0.82
0.19
1.0
1.0
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
438
2934
1.02
0.18
1.2
1.2
u/ml
1.9
7.0
2.45
33
234
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
438
2936
1.02
0.17
1.5
1.8
iu/l
6.2
15.1
0.54
110
1008
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
34
255
0.91
0.16
1.1
1.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
49
361
0.93
0.16
1.0
1.0
u/ml
0.1
0.3
—
8
57
(3027570) Oxalate [Moles/time] in 24 hour Urine
12
69
1.19
0.16
1.2
1.3
umol/24h
363.5
308.0
0.43
12
69
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
102
733
0.95
0.16
1.0
1.1
mg/l
318.2
289.4
0.43
86
655
(40762814) Titanium [Mass/volume] in Blood
56
359
1.07
0.16
2.1
2.3
ug/l
2.8
3.6
1.45
22
127
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
185
1226
1.03
0.16
1.1
1.1
—
29.6
—
0
12
(3014599) Egg white IgE Ab [Units/volume] in Serum
61
445
0.94
0.16
1.0
1.0
u/ml
0.7
0.5
—
10
111
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
6
54
0.76
0.16
13.0
9.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
11
63
1.20
0.15
5.9
1.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
231
1539
1.03
0.15
1.4
1.5
%
22.9
28.6
1.61
127
963
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
9
56
1.10
0.15
1.0
1.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
442
2972
1.02
0.14
1.2
1.2
u/ml
0.6
16.0
—
6
38
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
62
401
1.06
0.14
1.6
1.6
ug/l
9.9
9.1
0.71
62
401
(3039443) Prostate specific Ag panel - Serum or Plasma
317
2223
0.98
0.14
1.7
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
81
529
1.05
0.14
1.1
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
223
1571
0.97
0.14
1.1
1.1
%
117.9
118.5
0.09
198
1405
(3013166) Neutrophils/100 leukocytes in Synovial fluid
78
509
1.05
0.14
1.3
1.3
%
61.3
56.9
0.48
63
439
(3039162) Centromere protein B Ab [Units/volume] in Serum
254
1700
1.02
0.13
1.2
1.2
u/ml
62.2
56.9
0.11
19
123
(44813793)
133
881
1.04
0.13
1.1
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
28
176
1.09
0.13
1.6
1.6
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
63
455
0.95
0.13
1.0
1.1
%
101.2
98.1
0.21
48
349
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
103
679
1.04
0.12
1.4
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
70
457
1.05
0.12
1.5
1.5
—
—
—
0
0
(4306422)
232
1630
0.98
0.12
1.2
1.2
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
141
938
1.03
0.11
1.1
1.0
mg/l
302.7
287.8
1.61
121
844
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
24
151
1.09
0.11
1.2
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
30
191
1.08
0.11
1.2
1.9
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
175
1230
0.98
0.10
1.1
1.2
u/ml
110.0
60.6
—
9
57
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
82
541
1.04
0.10
3.1
3.0
umol/l
27.3
28.5
0.46
63
410
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
242
1627
1.02
0.10
1.1
1.1
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
30
192
1.07
0.10
1.3
1.3
mmol/l
7.3
6.6
0.25
13
94
(3012494) Peanut IgE Ab [Units/volume] in Serum
35
255
0.94
0.10
1.0
1.0
u/ml
0.8
1.0
0.08
13
121
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
75
534
0.96
0.09
1.1
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
71
468
1.04
0.09
1.1
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
18
135
0.91
0.09
1.1
1.1
u/ml
72.5
59.7
0.26
18
129
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
172
1206
0.98
0.09
1.1
1.1
%
97.6
95.0
0.65
158
1128
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
44
317
0.95
0.09
1.2
1.2
mg/l
1.2
21.7
0.71
31
240
(3008116) Ketones [Moles/volume] in Urine by Test strip
37
268
0.95
0.09
1.2
1.3
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
6
38
1.08
0.09
1.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
11
85
0.89
0.08
1.1
1.1
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
6
40
1.03
0.08
1.3
1.2
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
6
40
1.03
0.08
1.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
15
93
1.11
0.08
1.1
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
5
44
0.78
0.08
1.0
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
79
524
1.03
0.08
1.0
1.1
ng/l
682.6
753.5
0.05
20
124
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
7
45
1.07
0.08
1.1
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
77
511
1.03
0.08
1.7
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
506
3506
0.99
0.08
1.3
1.3
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
8
50
1.10
0.07
1.0
1.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
508
3517
0.99
0.07
1.2
1.3
u/ml
7.0
6.7
0.04
74
599
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
22
141
1.07
0.07
1.1
1.2
—
—
—
0
0
(44806071)
21
154
0.93
0.07
1.1
1.1
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
9
69
0.89
0.06
1.1
1.2
—
1.5
—
0
8
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
114
765
1.02
0.06
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
618
4206
1.01
0.06
1.8
1.7
—
—
—
0
0
(4211845)
114
766
1.02
0.06
4.0
3.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
649
4418
1.01
0.06
1.4
1.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
17
125
0.93
0.05
1.1
1.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
11
83
0.91
0.05
1.0
1.3
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
15
111
0.93
0.05
1.7
1.4
%
39.1
47.0
—
8
66
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
104
699
1.02
0.05
1.3
1.4
g/l
1.6
1.5
—
8
68
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
503
3474
0.99
0.05
1.2
1.3
u/ml
5.7
6.0
0.04
47
386
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
20
129
1.06
0.05
1.1
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
44
312
0.97
0.05
1.4
1.1
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
101
706
0.98
0.05
1.1
1.1
iu/ml
15.0
10.2
0.70
29
138
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
97
652
1.02
0.05
1.1
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
21
152
0.95
0.04
1.0
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
212
1437
1.01
0.04
3.4
2.9
mg/l
65.9
43.2
0.52
143
1022
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
1076
7346
1.00
0.04
1.2
1.2
iu/ml
118.2
135.3
0.80
343
2791
(3044009) aPTT.lupus sensitive (LA screen)
14
103
0.93
0.04
1.0
1.2
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
62
415
1.02
0.04
1.2
1.3
%
30.3
37.1
0.70
40
271
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
54
361
1.03
0.04
1.1
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
116
807
0.99
0.04
1.1
1.1
nmol/l
0.7
5.6
4.43
20
164
(3032743) Legionella sp IgG Ab [Presence] in Serum
16
103
1.07
0.03
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
295
2007
1.01
0.03
1.1
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
22
144
1.05
0.03
1.0
1.1
umol/24h
1.4
1.7
2.04
22
144
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
154
1067
0.99
0.03
1.1
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
55
369
1.02
0.03
1.2
1.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
10
63
1.09
0.03
1.5
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
97
674
0.99
0.02
8.0
4.6
u/ml
5224.8
494.1
0.51
26
108
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
203
1402
0.99
0.02
1.2
1.1
iu/ml
2.9
1.5
—
6
41
(3025018) Bordetella pertussis Ab [Titer] in Serum
91
632
0.99
0.02
1.4
1.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
555
3791
1.00
0.02
1.2
1.3
u/ml
47.3
43.1
0.09
27
228
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
29
193
1.03
0.02
3.4
2.8
u/field
0.7
0.6
0.25
29
193
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
151
1027
1.01
0.02
1.1
1.1
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
59
398
1.02
0.02
1.3
1.2
g/l
0.3
0.3
0.12
47
325
(3019174) dRVVT (LA screen)
15
108
0.95
0.01
1.0
1.2
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
37
259
0.98
0.01
2.1
1.6
mmol/l
1.2
1.2
0.38
37
250
(21494567) Legionella sp IgM Ab [Presence] in Serum
16
105
1.04
0.01
1.1
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
22
146
1.03
0.01
1.1
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
41
276
1.02
0.01
1.1
1.2
umol/l
17.9
16.5
1.06
34
252
(3001729) Color of Synovial fluid
19
135
0.96
0.01
1.3
1.6
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
94
639
1.01
0.01
1.1
1.1
ratio
1.1
1.1
0.10
24
216
(3000285) Sodium [Moles/volume] in Blood
33
231
0.98
0.01
1.1
1.2
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
18
119
1.04
0.01
1.1
1.1
u/ml
0.1
0.7
0.99
11
70
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
57
386
1.01
0.01
1.1
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
20
133
1.03
0.00
1.1
1.0
—
—
—
0
0
(4268621)
162
1115
1.00
0.00
2.3
2.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
389
2671
1.00
0.00
1.2
1.2
u/ml
48.4
50.4
0.07
35
281
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
10
65
1.05
0.00
1.1
1.0
mmol/l
8.0
8.7
—
10
65
(3011335) Digoxin [Mass/volume] in Serum or Plasma
21
145
0.99
0.00
2.8
2.3
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
16
113
0.97
0.00
1.3
1.6
%
1.7
0.7
0.47
11
90
(3005011) Chlamydia sp Ab [Titer] in Serum
23
161
0.98
0.00
1.8
1.7
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
11
78
0.97
0.00
2.4
1.9
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
12
86
0.96
0.00
1.0
1.2
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
58
396
1.00
0.00
1.6
1.6
ug/l
0.5
0.4
0.46
31
248
(3038177) Helicobacter pylori Ab [Presence] in Serum
274
1882
1.00
0.00
1.3
1.3
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
48
331
0.99
0.00
2.2
2.6
mmol/l
6.8
7.7
1.26
30
204
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
79
540
1.00
0.00
1.9
1.8
umol/l
86.7
114.3
0.78
42
280
(3047007) Chlamydophila sp Ab [Presence] in Serum
229
1572
1.00
0.00
1.3
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
17
117
1.00
0.00
1.0
1.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
54
370
1.00
0.00
1.3
1.2
%
113.4
113.8
0.04
49
325
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
44
304
0.99
0.00
1.1
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
172
1183
1.00
0.00
1.1
1.1
au/ml
131.3
52.7
—
5
25
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
44
299
1.01
0.00
3.2
2.9
mg/l
9.3
6.8
1.63
32
243
(3004616) Nuclear Ab [Presence] in Serum
264
1813
1.00
0.00
1.3
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
44
301
1.00
0.00
1.1
1.3
—
—
—
0
0
(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
5
34
1.01
0.00
1.0
1.2
mmol/l
—
—
—
0
0
(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
20.2
—
0
6
(3033463) Neutrophils [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36031836) Tocilizumab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
22.9
—
0
6
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015057) Respiratory syncytial virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
6
47
0.88
0.00
1.0
1.0
—
—
—
0
0
(3002853) Influenza virus B Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

Index endpoint: C3_OTHER_SKIN_EXALLC – Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

GWS hits: 86

This endpoint is excluded (different definition than used in FinnGen).